Search
Highlighting the specialty in the nation’s capital
During the 2023 AADA Legislative Conference almost 200 attendees urged Congress to protect physician payment and implement step therapy reform.
Advocacy Update Sept 16, 2025
The annual AADA Legislative Conference concluded Sept. 9, with advocates participating in over 200 meetings with congressional offices to urge Medicare physician practice payment reform.
Advocacy Update Sept 9, 2025
During a record-breaking Legislative Conference, more than 200 dermatologists and patient advocates gathered in Washington to urge Congress to reform Medicare physician payment.
Advocating for you — Highlighting the specialty in the nation’s capital
The messages you delivered to members of Congress in 200+ virtual meetings did not go unnoticed, and had a direct impact on legislation that affects you and your patients.
Are you at risk for pityriasis rubra type V? It’s in the cards!
In a recent post advising to tread lightly before prescribing secukinumab for pityriasis rubra pilaris (PRP), I suggested that the Griffiths classification of PRP be expanded from types I –VI to include type VII (paraneoplastic) and type VIII (Sézary syndrome presenting as PRP). In my opinion, of all the types,
Human papillomavirus (HPV)
Human papillomavirus comprises a family of more than 200 non-enveloped DNA viruses that selectively infect cutaneous and mucosal keratinocytes.
Dermatologists fight for Medicare physician payment reform
Over 200 dermatologists and patient advocates gathered in Washington, D.C., for the 2025 AADA Legislative Conference and asked Congress to reform Medicare physician payment — the AADA’s sole congressional advocacy priority.
Secukinumab for pityriasis rubra pilaris: Tread lightly
Every dermatology resident preparing for their board examination can rattle off Griffiths’ classification of pityriasis rubra pilaris (PRP) – Type I (Classical Adult), Type II (Atypical Adult), Type III (Classic Juvenile), Type IV (Circumscribed Juvenile), and Type V (Atypical Juvenile). Type VI, associated with HIV infection was subsequently added to
Members demand Medicare physician payment reform at AADA Legislative Conference
On Sept. 8, over 200 dermatologists and patient advocates gathered in Washington, D.C. to urge Congress to reform Medicare physician payment, AADA’s sole federal congressional priority. This was the largest Legislative Conference in the Academy’s history with over 190 advocates holding 217 meetings with their federal legislators.
Neurofibromatosis type 1, juvenile xanthogranuloma, and leukemia: Wasting a good worry?
Worry comes with the territory of Neurofibromatosis Type I (NF-1). It often starts with the anxiety of determining if a child has enough criteria to confirm the diagnosis.
Multiple café au lait spots in fair skinned children without evidence of neurofibromatosis type 1: Don’t SPRE(A)D the word – yet
Café au lait spots (CALS) are extraordinarily common; six or more lesions (at least 0.5 cm prior to puberty or 1.5 cm post puberty) are considered one of the criteria for diagnosing neurofibromatosis type I (NF1), and are also seen in a variety of other syndromes.
American Academy of Dermatology Association Applauds Introduction of The Patients First Act Aimed at Medicare Physician Reform
Statement from Murad Alam, MD, MSCI, MBA, FAAD, President, American Academy of Dermatology Association ROSEMONT, Ill. (July 15, 2026) — The American Academy of Dermatology Association applauds Academy member Representative John Joyce, MD, FAAD (R-PA), for introducing bipartisan, comprehensive Medicare physician payment reform legislation, the Patients First Act. The Academy
Getting a leg up on squamous cell carcinomas of the teratoacanthoma type
I thought it was my imagination, but apparently not – there is distinct subset of patients, mostly mature women, with squamous cell carcinomas (SCC) of the keratoacanthoma type (KA) usually presenting on the anterior distal lower extremities.
What's new in dermatology?
Experts break down diagnoses you didn't know about 10 years ago ... Feature ... By Emily Margosian, Assistant Editor, March 1, 2022 The history of medical diagnosis traces back to ancient Egypt, where the first recorded examples can be found in the writings of Imhotep dating 2630–2611 BC. In the
Future shock of teledermatology
Most respondents reported no concern about the safety of an e-visit compared with that of an office visit. When given a choice of cost of an e-visit [from $25 to $200] 40 (38.1%) respondents were unwilling to pay any amount out pocket for an e-visit, and 64 (61%) were willing
Gains in Patient Activation Measure (PAM) Scores at 12 Months — Measure 503
Access reporting information on measure 503: Gains in Patient Activation Measure (PAM) Scores at 12 Months. Review the maximum points available, the measure type, measure specifications, and much more.
Gains in Patient Activation Measure (PAM) Scores at 12 Months — Measure 503
Access reporting information on measure 503: Gains in Patient Activation Measure (PAM) Scores at 12 Months. Review the maximum points available, the measure type, measure specifications, and much more.
More than 200 AADA members, patients ask Congress to halt Medicare payment cuts, reform step therapy
Facts at your fingertips ... By Emily Margosian, Assistant Editor, January 1, 2022 The second annual AADA Virtual Legislative Conference again saw impressive participation numbers this past September, bringing key dermatologic issues before members of Congress. Attendees included physicians, residents, select medical students, dermatology nurses, and patient advocates. ... Participating
The Term “Dermal Hyperneury” Hits a Nerve
I was intrigued by the title “Dermal hyperneury and multiple sclerotic fibromas in multiple endocrine neoplasia type 2A spectrum” by Alegría-Landa et al. (1) [Please see the addendum for the definition of the multiple endocrine neoplasia (MEN) syndromes.]
Other emerging severe and resistant dermatophytes of concern
Other emerging dermatophytes of concern include Trichophyton rubrum and Trichophyton mentagrophytes type VII. Learn about treatment and patient counseling.
Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon – Part II – Focus on Anifrolumab
Anifrolumab, a monoclonal antibody that blocks type 1 interferon signaling, has been increasingly reported as an effective treatment in patients with recalcitrant chronic cutaneous lupus erythematosus.
Melanoma: Tracking and Evaluation of Recurrence — Measure 509
Access reporting information on measure 509: Melanoma: Tracking and Evaluation of Recurrence. Review the maximum points available, the measure type, measure specifications, and much more.
Melanoma: Tracking and Evaluation of Recurrence — Measure 509
Access reporting information on measure 509: Melanoma: Tracking and Evaluation of Recurrence. Review the maximum points available, the measure type, measure specifications, and much more.
Treatments for renal IgA vasculitis are beginning to flow
Renal disease is the most severe complication of IgA vasculitis. New treatments such as iptacopan (an alternative complement inhibitor) and atrasentan (an endothelin type A receptor inhibitor) are promising novel therapies for this challenging disease.
Melanoma Reporting — Measure 397
Access reporting information on measure 397: Melanoma Reporting. Review the maximum points available, the measure type, measure specifications, and much more.
Melanoma Reporting — Measure 397
Access reporting information on measure 397: Melanoma Reporting. Review the maximum points available, the measure type, measure specifications, and much more.
Adult Immunization Status — Measure 493
Access reporting information on measure 493: Adult Immunization Status. Review the maximum points available, the measure type, measure specifications, and much more.
Patient-Centered Surgical Risk Assessment and Communication — Measure 358
Access reporting information on measure 358: Patient-Centered Surgical Risk Assessment and Communication. Review the maximum points available, the measure type, measure specifications, and much more.
Patient-Centered Surgical Risk Assessment and Communication — Measure 358
Access reporting information on measure 358: Patient-Centered Surgical Risk Assessment and Communication. Review the maximum points available, the measure type, measure specifications, and much more.
Connection to Community Service Provider — Measure 498
Access reporting information on measure 498: Connection to Community Service Provider. Review the maximum points available, the measure type, measure specifications, and much more.
Quality Resources Provided by the AAD
See a summary of quality resources provided by the Academy, grouped by type.
Advance Care Plan — Measure 47
Access reporting information for MIPS measure 47: Advance Care Plan. Review the maximum points available, the measure type, measure specifications, and more.
Adult Immunization Status — Measure 493
Access reporting information on measure 493: Adult Immunization Status. Review the maximum points available, the measure type, measure specifications, and much more.
Advance Care Plan — Measure 47
Access reporting information for MIPS measure 47: Advance Care Plan. Review the maximum points available, the measure type, measure specifications, and more.
Screening for Social Drivers of Health — Measure 487
Access reporting information on measure 487: Screening for Social Drivers of Health. Review the maximum points available, the measure type, measure specifications, and much more.
Controlling High Blood Pressure — Measure 236
Access reporting information on measure 236: Controlling High Blood Pressure. Review the maximum points available, the measure type, measure specifications, and much more.
Medical research funding
Ask the Expert ... By Victoria Houghton, managing editor, August 1, 2021 DermWorld ... spoke to Jennifer Mangone, JD, manager of congressional policy for the American Academy of Dermatology Association (AADA), about the Academy’s advocacy efforts to support medical research funding. DermWorld: Advocating for medical research funding is a top
Documentation of Current Medications in the Medical Record — Measure 130
Access reporting information on measure 130: Documentation of Current Medications in the Medical Record. Review the maximum points available, the measure type, measure specifications, and much more.
Documentation of Current Medications in the Medical Record — Measure 130
Access reporting information on measure 130: Documentation of Current Medications in the Medical Record. Review the maximum points available, the measure type, measure specifications, and much more.
Psoriasis: Clinical Response to Systemic Medications — Measure 410
Access reporting information for MIPS measure 410: Psoriasis: Clinical Response to Systemic Medications. Review the maximum points available, the measure type, measure specifications, and much more.
Psoriasis: Improvement in Patient-Reported Itch Severity — Measure 485
Access reporting information for MIPS measure 485: Psoriasis: Improvement in Patient-Reported Itch Severity. Review the maximum points available, the measure type, measure specifications, and much more.
Dermatitis: Improvement in Patient-Reported Itch Severity — Measure 486
Access reporting information for MIPS measure 486: Dermatitis: Improvement in Patient-Reported Itch Severity. Review the maximum points available, the measure type, measure specifications, and much more.
Closing the Referral Loop: Receipt of Specialist Report — Measure 374
Access reporting information on measure 374: Closing the Referral Loop: Receipt of Specialist Report. Review the maximum points available, the measure type, measure specifications, and much more.
Closing the Referral Loop: Receipt of Specialist Report — Measure 374
Access reporting information on measure 374: Closing the Referral Loop: Receipt of Specialist Report. Review the maximum points available, the measure type, measure specifications, and much more.
Incretin-based therapy for diabetes and dermatology: Promise and peril
In a given day, how many of your patients are diabetic? According to the American Diabetes Association, in 2015, 9.4% of the US population (30.3 million) were diabetic; 29 million of this group had type 2 diabetes.
Psoriasis: Improvement in Patient-Reported Itch Severity — Measure 485
Access reporting information for MIPS measure 485: Psoriasis: Improvement in Patient-Reported Itch Severity. Review the maximum points available, the measure type, measure specifications, and much more.
Dermatitis: Improvement in Patient-Reported Itch Severity — Measure 486
Access reporting information for MIPS measure 486: Dermatitis: Improvement in Patient-Reported Itch Severity. Review the maximum points available, the measure type, measure specifications, and much more.
Psoriasis: Clinical Response to Systemic Medications — Measure 410
Access reporting information for MIPS measure 410: Psoriasis: Clinical Response to Systemic Medications. Review the maximum points available, the measure type, measure specifications, and much more.
October 23, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 23, 2024 ... Botulinum toxin type A with topical minoxidil vs. topical minoxidil alone in males with androgenetic alopecia DermWorld Insights and Inquiries : Shocking news — Heat shock protein
Chronic Skin Conditions: Patient Reported Quality-of-Life — QCDR measure AAD8
Access reporting information for QCDR measure AAD8: Chronic Skin Conditions: Patient Reported Quality-of-Life. Review the maximum points available, the measure type, measure specifications, and much more.
Actinic Keratosis: Self-reported AK Treatment or Management Outcomes — QCDR measure AAD 20
Access reporting information for QCDR measure AAD 20: Actinic Keratosis: Self-reported AK Treatment or Management Outcomes. This measure was developed by the AAD. Review the maximum points available, the measure type, measure specifications, and much more.
Avoidance of Opioid Prescriptions for Closures and Reconstruction After Skin Cancer Resection — QCDR measure AAD 18
Access reporting information for QCDR measure AAD 18: Avoidance of Opioid Prescriptions for Closures and Reconstruction After Skin Cancer Resection. Review the maximum points available, the measure type, measure specifications, and much more.
Use of High-Risk Medications in Older Adults — Measure 238
Access reporting information on measure 238: Use of High-Risk Medications in Older Adults. Review the maximum points available, the measure type, measure specifications, and much more.
Chronic Skin Conditions: Patient Reported Quality-of-Life — QCDR measure AAD8
Access reporting information for QCDR measure AAD8: Chronic Skin Conditions: Patient Reported Quality-of-Life. Review the maximum points available, the measure type, measure specifications, and much more.
Plantar melanoma and mechanical stress
Acral lentiginous melanoma (ALM) involves the palms, soles, and nail beds. It is the most common type of melanoma in patients of African or Asian descent. Delays in diagnosis result in more advanced disease at the time of diagnosis.
Melanoma: Appropriate Surgical Margins — QCDR measure AAD 12
Access reporting information for QCDR measure AAD 12: Melanoma: Appropriate Surgical Margins. This measure was developed by the AAD. Review the maximum points available, the measure type, measure specifications, and much more.
Decomplexing plexiform neurofibromas
Plexiform neurofibromas (PNs) are some of the most disfiguring and therapeutically challenging lesions that dermatologists confront. PNs are mostly associated with autosomal dominant neurofibromatosis type 1. Rarely, they may also be seen in germline p16 mutation-positive heritable melanoma and Cowden syndrome.
Glomus tumors point a finger at neurofibromatosis
The correct diagnosis of the JAMA Dermatology Clinicopathological Correlation of a glomus tumor presenting as longitudinal erythronychia was straightforward – I was fascinated by this comment in the discussion: “The presence of multiple glomus tumors in the digits should raise suspicion for neurofibromatosis type I” (1).
Melanoma: Appropriate Surgical Margins — QCDR measure AAD 12
Access reporting information for QCDR measure AAD 12: Melanoma: Appropriate Surgical Margins. This measure was developed by the AAD. Review the maximum points available, the measure type, measure specifications, and much more.
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented — Measure 317
Access reporting information for MIPS measure 317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented. Review the maximum points available, the measure type, a measure flowchart, measure specifications, and much more.
Biopsy: Reporting Time - Clinician to Patient — QCDR measure AAD 6
Access reporting information on QCDR measure AAD6: Skin Cancer: Biopsy Reporting Time — Clinician to Patient — Measure AAD 6. This measure was developed by the AAD. Review the maximum points available, the measure type, measure specifications, and much more.
Biopsy: Reporting Time - Clinician to Patient — QCDR measure AAD 6
Access reporting information on QCDR measure AAD6: Skin Cancer: Biopsy Reporting Time — Clinician to Patient — Measure AAD 6. This measure was developed by the AAD. Review the maximum points available, the measure type, measure specifications, and much more.
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling — Measure 431
Access reporting information on measure 431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling. Review the maximum points available, the measure type, measure specifications, and much more.
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling — Measure 431
Access reporting information on measure 431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling. Review the maximum points available, the measure type, measure specifications, and much more.
Actinic Keratosis: Self-reported AK Treatment or Management Outcomes - National Quality Strategy Domain: Patient Experience — QCDR measure AAD 20
Access reporting information for QCDR measure AAD 20: Actinic Keratosis: Self-reported AK Treatment or Management Outcomes - National Quality Strategy Domain: Patient Experience. This measure was developed by the AAD. Review the maximum points available, the measure type, measure specifications, and much more.
Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis — QCDR measure AAD15
Access reporting information for QCDR measure AAD 15:Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis. This measure was developed by the AAD. Review the maximum points available, the measure type, measure specifications, and much more.
Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis — QCDR measure AAD15
Access reporting information for QCDR measure AAD 15:Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis. This measure was developed by the AAD. Review the maximum points available, the measure type, measure specifications, and much more.
Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures — QCDR measure AAD16
Access reporting information for QCDR measure AAD16: Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures. Review the maximum points available, the measure type, measure specifications, and much more.
Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures — QCDR measure AAD16
Access reporting information for QCDR measure AAD16: Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures. Review the maximum points available, the measure type, measure specifications, and much more.
Continuation of Anticoagulation Therapy in the Office-based Setting for Closures and Reconstruction After Skin Cancer Resection Procedures — QCDR measure AAD 17
Access reporting information for QCDR measure AAD 17: Continuation of Anticoagulation Therapy in the Office-based Setting for Closures and Reconstruction After Skin Cancer Resection Procedures. Review the maximum points available, the measure type, measure specifications, and much more.
Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time — Pathologist to Clinician — Measure 440
Access reporting information for MIPS measure 440: Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time — Pathologist to Clinician. Review the maximum points available, the measure type, measure specifications, and much more.
Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time — Pathologist to Clinician — Measure 440
Access reporting information for MIPS measure 440: Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time — Pathologist to Clinician. Review the maximum points available, the measure type, measure specifications, and much more.
Appropriate Documentation and Shared Decision Making of AK — QCDR measure AAD 21
Access reporting information for QCDR measure AAD 21: Appropriate Documentation and Shared Decision Making of AK. This measure was developed by the AAD. Review the maximum points available, the measure type, measure specifications, and much more.
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention — Measure 226
Access reporting information on measure 226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention. Review the maximum points available, the measure type, a measure flowchart, measure specifications, and much more.
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention — Measure 226
Access reporting information on measure 226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention. Review the maximum points available, the measure type, a measure flowchart, measure specifications, and much more.
Types of audits
There are four different types of Medicare contractors that are responsible for auditing records, claims, and payments. While each type of contractor can use different methods to conduct the appeals, they all must be compliant with Medicare guidelines for medical review, denials, appeals, and payment recovery.
Addressing systems and administrative challenges
Running a successful dermatology practice hinges not only on exceptional patient care but also on efficient administration. While challenges vary based on practice type and other factors, most practices face common administrative burdens. These burdens are a major driver of burnout.
Do skin cancer rates differ by transplanted organ type and patient age?
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, March 1, 2023 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Lee Wheless, MD,
October 12, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 12, 2022 ... Type 2 diabetes and CCCA severity DermWorld Insights and Inquiries : Fixing the concept of the neutrophilic fixed drug eruption What’s the risk of IBD in patients
Melanoma risk in patients with melaoncortin-1 receptor independent of ultraviolet radiation: Is there a way not to be burned by your genome?
I admit that my concept of Type I skin red-headed patients getting melanoma was simple: They have a polymorphism(s) of the melanocortin-1 receptor (MC1R), pheomelanin, ultraviolet exposure, DNA damage, increased reactive oxygen species, and voila: melanoma! While conceptually elegant, this is apparently only a partial truth.
Breaking through
Go to AAD Home ... Go to AAD Home ... Menu ... Advances in disease pathogenesis and treatments offer new promise for patients with connective tissue disease ... Advances in disease pathogenesis and treatments offer new promise for patients with connective tissue disease ... By Allison Evans, assistant managing editor
AADA members and their patients bring key dermatologic issues to the Hill
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, January 1, 2023 The AADA Legislative Conference returned in-person to Capitol Hill this past September, bringing critical dermatologic issues before members of Congress. Attendees included physicians, patients, patient advocates, and dermatology practice administrators. ... AADA members unable to attend the
October 14, 2026
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 14, 2026 ... JAK inhibitors in older adults: A practical guide to drug selection, dosing DermWorld What’s Hot: ‘Big Wellness’ industry Dermoscopic pitfall in pigmented BCC Can botulinum toxin improve
What's new in treating connective tissue disease
Dermatologists discuss the latest advances in treating cutaneous lupus, dermatomyositis, and systemic sclerosis. ... Feature ... By Allison Evans, Assistant Managing Editor, July 1, 2023 There are more than 200 disorders included within the term "connective tissue disease." Some of these disorders predominantly affect the skin or have skin-related implications,
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented — Measure 317
Access reporting information for MIPS measure 317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented. Review the maximum points available, the measure type, a measure flowchart, measure specifications, and much more.
Looking back on 2023.
From the President ... Dr. Cronin served as Academy president from March 2023 to March 2024. ... By Terrence A. Cronin Jr., MD, FAAD, December 1, 2023 2023 was an exciting year, and one during which I was proud to lead the Academy. We made massive steps toward boosting the
Ustekinumab: A topic for atopics?
If you’re like me, you have a cadre of patients with severe atopic dermatitis (AD) patients who are counting the minutes for the release of dupilimab (a human monoclonal antibody against interleukin-4 receptor alpha, that inhibits signaling of interleukin-4 and interleukin-13, type 2 cytokines that may be important drivers of
Leading when you’re not the practice owner
Answers in Practice ... By Megan Bennett, Staff Writer, November 1, 2025 DermWorld ... talks to Sama Carley, MD, FAAD, chief of dermatologic surgery at Sharp Rees-Stealy in San Diego, about exhibiting leadership qualities even when you don’t lead the practice. DermWorld: Tell us about your practice. Dr. Carley: The
New treatments provide more options for people with alopecia areata
Journal of the American Academy of Dermatology ... article highlights new ways to restore hair ROSEMONT, Ill. (Aug. 15, 2023) — A study published today in a supplement of the ... Journal of the American Academy of Dermatology titled " ... Alopecia: A New Frontier " reveals that a new
New study reveals that some children with common form of eczema should also be tested for allergic reactions
Study author highlights test used to differentiate between two types of eczema ROSEMONT, Ill. (September 26, 2023) — Eczema, which is a group of medical conditions that causes inflamed, irritated, and often itchy skin, affects millions of people worldwide. A new article published in the ... Journal of the American
Becoming pro-geriatric by understanding progeria
I have never seen a case of Hutchinson-Gilford progeria syndrome (HGPS). You probably haven’t either, given its incidence of 1 in 4 million. Why comment on a disease that will likely only be seen in a texbook?
Tressed to impress: tips for keeping your mane magnificent
6 tips for healthier looking and feeling hair from a board-certified dermatologist ROSEMONT, Ill. (Aug. 13, 2024) — Hair is as unique as its wearer, making care an important aspect in one’s overall health and wellness routine. From understanding your hair type to learning the best shampooing technique (yes, there
Session handouts and meetings archive
View previous AAD meeting sessions, handouts, poster exhibits, and floor plans.
Membership Committee portal
Welcome to the American Academy of Dermatology’s Membership Committee portal. The portal houses applications and their supporting documentation along with resources to help determine eligibility for membership. ... Applicant Name ... Type ... Category ... Country ... Status ... Review {{application.fullName}} ... {{application.pendingMemberType}} ... {{application.pendingMemberCategory}} ... {{application.businessAddressCountry}} ... {{application.status}} ...
Granulomatous slack skin: More than one type of mimicry
Read the November 18, 2020 DermWorld Insights and Inquiries on granulomatous slack skin.
Looking beyond ‘Ozempic face’
Dermatologists weigh in on cutaneous side effects of GLP-1 agonists. ... Feature ... By Emily Margosian, Senior Editor, November 1, 2025 Glucagon-like-peptide-1 (GLP-1) agonists are an emerging class of medications used to manage type 2 diabetes mellitus (T2DM) and weight loss, with demonstrated efficacy in reducing hemoglobin A1c levels, body
March
Issue ... March January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... I always knew firefighting was a dangerous occupation What’s hot ... This month’s news from across the specialty Clinical Applications ... Do skin cancer
Malpractice insurance 101
Experts offer advice on navigating malpractice insurance policies. ... Feature ... By Andrea Niermeier, Contributing Writer, February 1, 2025 While medical malpractice suits first regularly appeared in the United States in the 1800s, the frequency of claims has only increased since the 1960s, with lawsuits relatively common today. Medical malpractice
The doctor will see you...soon?
Facts at your Fingertips ... By Emily Margosian, assistant editor, July 1, 2019 As efforts to improve access to dermatologic care remain ongoing (Read ... Dermatology World ’s 2017 feature "Access Granted" at ... www.aad.org/dw/monthly/2017/october/access-granted for strategies to broaden patient access), how long can the average patient expect to wait
The retiring type?
“Tell me, Dr. Heymann, when do you plan to retire?” Patients seem to ask me that every day. My usual response: “Why do you ask, do I look that bad?” “No, you look pretty good for your age.” (According to my rabbi, there are three stages of life – youth, middle age, and
Advocacy Update Feb. 4 2025
The AADA is pleased that physician champions in the U.S. House introduced a bipartisan bill to address the 2025 Medicare Physician Fee Schedule cut.
Advocacy Update June 30, 2026
AADA President Murad Alam, MD, MSCI, MBA, FAAD, met with federal legislators on Medicare physician payment reform in Washington, DC.
Advocacy Update May 5, 2026
In response to advocacy by the AADA and other specialty societies, UnitedHealth Care will delay any adverse payment decisions related to Medicare Advantage referral requirements starting on May 1.
November 18, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / November 18, 2020 ... Hydrogen peroxide and the common wart: Phase 2 results are in DermWorld Insights and Inquiries : Granulomatous slack skin — More than one type of mimicry FDA
Dermatology antibiotic prescription trends
Facts at your fingertips ... By Emily Margosian, assistant editor, November 1, 2019 As antibiotic resistance has increasingly captured the attention of the media and global health organizations, physicians have found themselves under more pressure to monitor their antibiotic prescription habits. Although overall antibiotic prescribing by dermatologists decreased by 36.6%
Melanoma incidence rising, deaths decreasing
Facts at your fingertips ... By Emily Margosian, assistant editor, December 1, 2019 According to data from the National Institutes of Health (NIH) Surveillance, Epidemiology, and End Results Program (SEER), there were an estimated 96,480 new cases of melanoma of the skin in 2019 — making it the fifth most
Demand for cosmetic procedures resumes after COVID
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, April 1, 2023 During the start of the COVID-19 pandemic, many practices paused elective and cosmetic procedures for several weeks, followed by further disruptions due to the ebb and flow in national and regional caseloads. ... The release of new
Ransomware attacks on U.S. health care double
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, February 1, 2024 Ransomware is on the rise. A recent ... JAMA Health Forum study found that the annual number of ransomware attacks on health care organizations more than doubled from 2016 to 2021, exposing the personal health information (PHI)
COVID’s impact on cosmetic procedures
Facts at your fingertips ... By Emily Margosian, Assistant Editor, April 1, 2022 During the start of the COVID-19 pandemic, many practices paused elective and cosmetic procedures for several weeks, followed by further disruptions throughout the year due to the ebb and flow in national and regional caseloads. The release
This month’s news from across the specialty
What’s hot ... August 1, 2024 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Maureen Offiah, MD, FAAD Several physician groups have recently modified the ... staging and classification of all primary cutaneous lymphomas (PCL). Changes to
AAD membership at a glance
Facts at your Fingertips ... By Emily Margosian, content specialist, June 1, 2018 Which way are the winds of dermatology blowing? AAD membership data may serve as a bellwether. In 2018, overall membership surpassed 20,000 dermatologists, but beyond hitting the 20K mark, other demographic changes regarding gender and practice type
Advocacy Update Dec 9, 2025
The AADA endorsed a House bill that would include an annual inflationary update to the Medicare physician fee schedule, the Academy’s top federal advocacy priority.
What's hot?
What's hot ... February 26, 2019 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD ... Isn’t it interesting how some common warts that we treat seem to go away almost instantly but others persist
4 cradle cap tips from dermatologists
Tips from board-certified dermatologists ROSEMONT, Ill. (August 18, 2022) — Bringing home a new baby is a joyous time for any parent. For first time parents, bringing home a new baby can unlock a wide range of emotions—from excitement to nervousness. As you adjust to parenthood, you’ll notice that your
How to prevent keloid scars
Board-certified dermatologist shares tips to reduce your risk ROSEMONT, Ill. (Dec. 6, 2023) — Keloids are a type of raised scar that can occur after an injury, and over time they can grow much larger than the wound itself. Although keloids are not dangerous to a person’s health, they can
Advocacy Update Feb. 18 2025
The AADA joined over 130 national and state physician organizations led by the AMA demanding Congress act to reform Medicare physician payment.
Advocacy Update Mar. 18, 2025
The AADA is outraged that Congress once again passed a government funding bill that did not include relief to stop this year’s 2.8% Medicare physician payment cut.
CME & session evaluation archive
Claim CME credit and submit session evaluations for attending previous Academy meetings.
Unrestricted fascination with restrictive dermopathy
Read the Nov. 16, 2022 DermWorld Insights and Inquiries on restrictive dermopathy.
Alleviate the ouch
Experts share best practices and review the latest on safety concerns for anesthesia use in children. ... Feature ... By Heidi Splete, Contributing Writer, May 1, 2024 Use of anesthesia can be tricky in adults, but even trickier in children. The use of local or general anesthesia in pediatric dermatology
Contract reimbursement review
When deciding whether to sign a contract with a payer, reimbursement is one of the most important considerations. Adequate reimbursement is critical to the viability of your practice. Therefore, be sure to review contract language on reimbursement carefully. ... Aspects of reimbursement are often negotiable, though the extent to which
AADA hosts largest Capitol Hill skin cancer check in a decade
On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health Fair with the Congressional Skin Cancer Caucus. This event was our largest to date, hosting 198 Hill staffers and 11 members of Congress, performing 127 skin checks, and providing 75 Reveal camera image results.
Are teens tanning less?
Go to AAD Home ... Go to AAD Home ... Menu ... Signs point to progress, but work remains ... Signs point to progress, but work remains ... By Ruth Carol, contributing writer It appears that fewer teens are indoor tanning in recent years, but the data are sparse. Regulations
Academy physician leaders meet with federal legislators
On June 4, AADA physician leaders met with legislators in Washington, D.C., as part of the House Call on the Mall fundraiser hosted by the National Republican Congressional Committee and Rep. John Joyce, MD, FAAD (R-PA). During the event, AADA leaders reiterated the importance of Medicare physician payment reform.
CBD: Potential or placebo?
Go to AAD Home ... Go to AAD Home ... Menu ... Potential applications and concerns regarding the use of cannabinoids in dermatology ... Potential applications and concerns regarding the use of cannabinoids in dermatology ... By Emily Margosian, assistant editor This recent Mother’s Day holiday, shoppers may have observed
Researching therapeutic reformation of the capillary malformation: Arteriovenous Malformation Syndrome
Read the June 17, 2020 DermWorld Insights and Inquiries on capillary malformation.
AADA hosts 10th annual Capitol Hill Skin Cancer Check and Health Fair
Moving the needle ... By Apoorva Stull, Senior Manager, Advocacy Communications, May 1, 2024 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health
Glucose monitors: Not as sweet as they seem
Learn more about Glucose monitors: Not as sweet as they seem at aad.org
Recognizing Trichophyton indotineae
In the last decade, a recently emerged dermatophyte species, Trichophyton indotineae, has been causing major outbreaks of severe, difficult-to-treat, and frequently relapsing infections in South Asia among immunocompetent patients.
Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon
Read the Aug. 17, 2022 DermWorld Insights and Inquiries on cutaneous lupus erythematosus and interferon.
2025 MIPS and telehealth highlights
The 2025 MIPS program features some changes, including the introduction of a MIPS value pathway for dermatology. See our highlights on what dermatologists need to know about participating in MIPS.
MIPS Highlights for 2021
Access the Academy's highlights of the Final Rule for MIPS for the 2021 reporting year. These updates are tailored to include the information most important to dermatologists. Program updates for 2021 are relatively modest compared to some previous years, but higher participation thresholds and other changes merit careful review.
MIPS 2022 program highlights
Learn about important updates to the Merit-based Incentive Payment System (MIPS) for 2022. Learn about new eligibility requirements, thresholds, category weights, and more.
Elmer Fudd beware: Tularemia’s re-emergence
Practicing dermatology is humbling business. I tip my hat to Polat et al, who diagnosed tularemia in an 11 year-old girl presenting with targetoid papules and plaques of her face, trunk, and extremities (diagnosed as erythema multiforme minor).
Advocacy Update Sept. 29, 2026
SkinPAC surpasses its previous fundraising record, raising more than one million dollars.
International Associate membership | AAD
Information about International Associate membership in the American Academy of Dermatology. Learn about eligibility, the timeline, documentation, dues and fees, and how to apply.
The Venetian antithesis: Treating median canaliform nail dystrophy
Median canaliform nail dystrophy is easy to recognize but difficult to treat. Recent reports utilizing tazarotene foam, dupilumab, and marigold offer some promise that warrant further study with appropriate trials.
Public health programs
By communicating these key messages on public health programs, you can help position the specialty while increasing your credibility and raising the profile of your practice. Efforts include the skin cancer screening program, the shade structure program, Camp Discovery, and more.
International Fellow membership | AAD
Information about International Fellow membership in the American Academy of Dermatology. Learn about eligibility, the timeline, documentation, dues and fees, and how to apply.
Advocacy Update Feb 3, 2026
The Academy continues to monitor the current partial government shutdown and its impact on dermatologists. The funding bill that is in debate includes HHS with Department of Homeland Security funding.
Surviving and thriving after a natural disaster
Answers in Practice ... By Emily Margosian, Assistant Editor, September 1, 2023 DermWorld ... talks to Mary Lupo, MD, FAAD, from the Lupo Center for Aesthetic and General Dermatology in New Orleans, about how to prepare your practice for a natural disaster. Mary Lupo, MD, FAAD ... DermWorld: Tell us
Taking the challenge: Social media, adolescents, and the skin
Learn more about Taking the challenge: Social media, adolescents, and the skin at aad.org
2023 MIPS and telehealth highlights
The 2023 MIPS program remains mostly the same from 2022, but there are also important changes, such as the end of performance bonuses, the start of MVPs, and more.
The vexing verruciform xanthoma
Read the February 24, 2022 DermWorld Insights and Inquiries on verruciform xanthoma.
Advocacy Update Mar. 4, 2025
The Academy urged CMS and CDC to recognize dermatologists as Clinical Laboratory Improvement Amendments (CLIA) laboratory directors.
2024 MIPS and telehealth highlights
The 2024 MIPS program remains mostly the same from 2023. See our highlights on what dermatologists need to know about participating in MIPS.
Advocacy Update July 21, 2026
New legislation introduced would modernize the Medicare physician payment system.
Advocacy Update July 28, 2026
President’s message on Academy’s efforts on fighting proposed Dermatology cuts.
Emerging diseases resource center
The Academy has curated and developed these scientific resources to assist members in the recognition, management, and reporting of emerging threats.
October 27, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 27, 2021 ... COVID-19 and nails: A review of clinical findings DermWorld Insights and Inquiries : Taking woolly hair to heart Derm Coding Consult : CMS revises Advance Beneficiary Notice
2026 MIPS and telehealth highlights
The 2026 MIPS program features some changes, including the continuing rollout of the MIPS Value Pathway for dermatology. See our highlights on what dermatologists need to know about participating in MIPS.
Advocacy Update Jul 22, 2025
The AADA submitted nomination materials recommending AADA Dermatopathology Committee Chair Alina Bridges, DO, FAAD, for membership on the CDC’s Advisory Committee to the Director.
Fixating on doxycycline-induced fixed drug eruptions
Dermatologists routinely prescribe doxycycline. Historically, doxycycline rarely causes a fixed drug eruption. A case series of patients with doxycycline-induced fixed drug eruptions in patients receiving doxycycline for post-exposure prophylaxis or treatment of sexually transmitted disease has been reported. More study is required to determine if the incidence of doxycycline-induced fixed
A potential roadMAP for treating malignant atrophic papulosis
DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, June 1, 2026 Vol. 8, No. 6 Certain skin lesions evoke dread in the dermatologist who encounters them, fearing a poor prognosis for their patient. Examples include a Sister Mary Joseph nodule, a thick melanoma, or rhinocerebral mucormycosis, among
2026 AADA Legislative Conference: Program and agenda
Learn more about the policy-focused sessions during the 2026 AADA Legislative Conference.
The rosy reality of coffee
I have never discouraged caffeine in rosacea patients, because of a brilliant study by Jonathan Wilkin that I read early in my residency.
This month's news from across the specialty
What's hot ... January 1, 2022 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Sylvia Hsu, MD, FAAD Diagnostic conundrums are often presented at dermatology teaching conferences in which the presenter asks the audience for a differential
Preventing and treating Trichophyton indotineae
Because confirmatory testing may take weeks, it is reasonable to empirically start treatment for T. indotineae based on patient epidemiologic and clinical features while awaiting confirmatory testing. Potassium hydroxide (KOH) preparation of skin scrapings should be performed in clinic, whenever possible, to confirm fungal infections.
Step 1: Check participation requirements
The first step of the Academy's 3-step MIPS guide enables dermatologists to determine whether they are exempt from MIPS reporting. Dermatologists who do not meet certain Medicare participation thresholds are not subject to MIPS reimbursement penalties, though they optionally participate to earn incentives.
2025 AADA Legislative Conference: Program and agenda
Learn more about the policy-focused sessions during the 2025 AADA Legislative Conference.
My fair-weather therapeutic friends for alopecia areata
We were never best of friends, but we got along well most of the time. The relationship seemed to work, with rare moments of ecstasy, but was irritating all too often. There were no major conflagrations; we just drifted apart.
What's hot?
What's hot ... June 28, 2018 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD ... "SPF 30 or higher" is the classic, impulse response that we often give when asked about sunscreen recommendations. However,
Highlighting the specialty in the nation’s capital
The Academy’s advocacy power comes from the voices of our members. At the Academy, we make it easy for your voice to be heard on the issues that matter most to your patients and practices.
Gold Medal Award
The Gold Medal award is the Academy’s highest honor. It is presented on a highly selective basis in recognition of outstanding and exceptional service to the specialty of dermatology in the science, teaching and practice of cutaneous medicine and surgery. It is also considered for those who have made an
AADA members and their patients bring key dermatologic issues to the Hill
At the Academy, we make it easy for your voice to be heard on the issues that matter most to your patients and practices. This year, the AADA Legislative Conference returned in-person to Capitol Hill, giving dermatologists the opportunity to bring key dermatologic issues before members of Congress. Attendees included
May 26, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 26, 2021 ... Managing itch: Wearable sensor quantifies symptoms DermWorld Insights and Inquiries : Stevens-Johnson Syndrome-toxic epidermal necrolysis — The aftermath Bringing diversity to Academy committees and task forces Is
Key messages to communicate about Indoor tanning
By communicating these key messages on indoor tanning, you can help position the specialty while increasing your credibility and raising the profile of your practice.
Vaccines, maintenance, and PEP
Learn about vaccine status based on birth year and high-risk individuals who should have vaccine boosters. Also, see our resources on post-exposure prophylaxis (PEP) and administering immunoglobulin.
Olmsted syndrome patients can finally put their foot down
Read the January 20, 2021 DermWorld Insights and Inquiries on Olmsted syndrome.
Preparing for 2025 MIPS and the new dermatological care MVP
Answers in Practice ... By Oliva Barry, Manager, Practice Management, April 1, 2025 Each month, DermWorld ... tackles issues "in practice" for dermatologists. This month, practice management staff discuss what to expect for MIPS 2025. MIPS program timeline ... In November, CMS released the ... final rule for the Quality
Advocating on behalf of dermatology is an enduring obligation
From the President ... Dr. Hruza served as Academy president from March 2019 to March 2020. ... By George Hruza, MD, MBA, December 1, 2019 The year is winding down, and as usual I find myself reminiscing about the last 12 months — thinking about all of the patients I
September 30, 2026
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 30, 2026 ... Oral finasteride, dutasteride for female pattern hair loss and frontal fibrosing alopecia DermWorld What’s Hot: Finding the right skin cancer screening cadence Academy mourns the passing of
January
Issue ... January January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... More unintended consequences What's hot ... This month's news from across the specialty Clinical Applications ... What is the economic burden of drug utilization
Advocacy — 2021 AADA Virtual Legislative Conference
During the second annual AADA Virtual Legislative Conference, held on Sept. 23-28, we brought the most vital dermatologic issues to members of Congress, and it made a difference. Notably, more than 150 of you advocated for Medicare stability and step therapy reform.
Your Dermatologist Knows see major traditional media successes
As the success of Your Dermatologist Knows continues into its third year, so too do the efforts of the Academy’s media relations team to spread the word about the knowledge and expertise that only a board-certified dermatologist has on skin, hair, and nail conditions.
Get ready for MIPS in 2019
In Practice ... Faiza Wasif, MPH, is the AAD's practice management manager. Her column offers tips on an area she commonly receives questions about from members. ... By Faiza Wasif, MPH, February 1, 2019 CMS has made several changes to the 2019 Merit-based Incentive Payment System (MIPS). While CMS did
September 8, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 8, 2021 ... A review of spironolactone for androgenetic alopecia DermWorld Insights and Inquiries : Alarming but benign – The enigma of acute hemorrhagic edema of infancy What are the
May 18, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 18, 2022 ... Abrocitinib efficacy after switching from dupilumab DermWorld Insights and Inquiries : Coming to grips with lymphocytic thrombophilic arteritis DermWorld Young Physician Focus : Protecting dermatologic scope of
Advocacy Update Aug 12, 2025
The AADA asked congressional leadership to support the SAFE Sunscreen Standards Act by including it in the reauthorization of the Over-the-Counter Monograph Drug User Fee Program.
October 10
Learn more about October 10 at aad.org
MIPS requirements for 2022
Answers in Practice ... By Faiza Wasif, MPH, Associate Director, Practice Management, June 1, 2022 Each month, DermWorld tackles issues "in practice" for dermatologists. This month, practice management staff discuss MIPS requirements. CMS published new requirements for the Merit-based Incentive Payment System (MIPS) for 2022. Review a summary of highlights
Pathways: Pre-med students
Do you enjoy STEM subjects but also want a career that involves connecting with people? You may want to consider medicine and, specifically, dermatology. And the AAD’s Pathways: Inclusivity in Dermatology program can help start you way to this exciting career. This program is designed for pre-med and postbaccalaureate students.
2018: Merit-based Incentive Payment System (MIPS)
Learn about important updates to the Merit-based Incentive Payment System (MIPS) that occurred in 2018. This information may be useful to dermatologists who wish to understand their payment year results in 2020. It may also be useful to those who wish to better understand how the MIPS program has evolved
About the Academy
The American Academy of Dermatology is a non-profit medical specialty association that was founded in 1938. All the work we undertake on behalf of our members, their patients, and the public is guided by a clear vision of being recognized as the leading authority for the highest quality and compassionate dermatologic care, and
Shedding light on treatments for female pattern hair loss
Dermatologist hair experts discuss the efficacy and safety considerations of off-label treatments for female pattern hair loss. ... Feature ... By Allison Evans, Assistant Managing Editor, April 1, 2025 A female patient presents with thinning hair and a reduction in hair density at the top of the scalp. Is it
October 2, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 2, 2024 ... Risk of IBD in patients receiving isotretinoin DermWorld Insights and Inquiries : The pregnant pause in cutaneous lymphoma Hydroxychloroquine in patients with lichen sclerosus Abrocitinib vs. dupilumab
Beyond dermoscopy
Emergent technologies enhance imaging, target rare diseases. ... Feature ... By Jan Bowers, Contributing Writer, August 1, 2023 Dermoscopy has arrived. "While there are established practicing dermatologists who are not using it, it’s integrated across the residency programs," said Ashfaq A. Marghoob, MD, FAAD, attending physician at Memorial Sloan Kettering
What are AAD Expert Resource Groups (ERGs) and how can I get involved?
Asked and Answered ... January 1, 2022 The Academy’s Expert Resource Groups (ERGs) are made up of individuals who come together to share information and knowledge about a particular topic, usually specific diseases or issues relevant to dermatology. ... You do not need to be an expert on an ERG’s
Impact Report — Vol 5, Issue 3
Your Academy continues to protect and advance our specialty where it matters most. We advocated for fair payment, defended against inappropriate step therapy protocols, raised the visibility of dermatology, expanded CME access, and strengthened our member community.
Dermatologists, patients unite to battle 2024 Medicare physician payment cuts
In late 2023, CMS released the 2024 Medicare Physician Fee Schedule rule with significant changes to fee-for-service payments and the Quality Payment Program. As a result of the AADA’s advocacy efforts, the final rule included several significant wins, including maintaining the 2024 MIPS performance threshold at 75 points, and allowing physicians
Dupilumab’s growing pains
Read the January 8, 2020 DWII on dupilumab.
Biotin supplementation for hair and nail health: Does it pass the test?
Read the November 17, 2021 DermWorld Insights and Inquiries on biotin supplementation for hair and nail health.
After 23 years, a syndrome converted me into an eflornithine believer
Polyamines are integrally involved with the hair cycle. The Bachmann-Bupp syndrome has shed new light on the role of ornithine decarboxylase, and how it’s inhibition by eflornithine can be used as an advantage to either slow or stimulate hair growth.
Preparing for MIPS 2023 and beyond
Answers in Practice ... By Olivia Barry, Manager, Practice Management, April 1, 2023 Each month, DermWorld ... tackles issues "in practice" for dermatologists. This month, practice management staff offer tips on MIPS reporting. It’s year five of the Merit-based Incentive Payment System (MIPS), so you are probably well aware that
What to expect for MIPS 2024
Answers in Practice ... By Olivia Barry, Manager, Practice Management, April 1, 2024 Each month, DermWorld ... tackles issues "in practice" for dermatologists. This month, practice management staff explains what to expect for MIPS 2024. On Nov. 2, 2023, CMS released the final Quality Payment Program (QPP) Rule which includes
July 4
Learn more about July 4 at aad.org
July 2, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 2, 2025 ... Isotretinoin for seborrheic dermatitis DermWorld Insights and Inquiries : Turning our attention to melanoma risk in Turner syndrome CMS updates MUE limit for Ameluz — Effective July
Advocacy Update 2025 archive
Explore Advocacy Update articles by publication date in this archive of issues published in 2025.
Your Dermatologist Knows continues to show strong results
Launched in October 2022, the Your Dermatologist Knows consumer positioning strategy has been successful in its goal of increasing awareness of the specialty and positioning board-certified dermatologists as the go-to experts for conditions affecting skin, hair, and nails. There are two main components of the strategy: social media and traditional
Academy continues to fight for Medicare physician payment reform
The Academy made Medicare physician payment reform its sole legislative advocacy focus and will continue to do so in 2026. Our goal is to stop annual payment cuts and for Congress to pass legislation that guarantees an annual update based on inflation.
Support the Leadership Institute
The AAD’s Leadership Institute gives dermatologists the skills to succeed and become leaders in their communities. Learn more about how you can help support the Leadership Institute program.
Fellow membership | AAD
Information about Fellow membership in the American Academy of Dermatology. Learn about eligibility, the timeline, application requirements, dues and fees, and how to apply.
Affiliate membership | AAD
Information about Affiliate membership in the American Academy of Dermatology. Learn about eligibility, the timeline, application requirements, dues and fees, and how to apply.
The role of GLP-1s in dermatology
Dermatologists discuss how the use of GLP-1s has offered potential new avenues for patients with chronic inflammatory skin diseases. ... Feature ... By Allison Evans, Assistant Managing Editor, January 1, 2026 Over the past five years, the approvals of glucagon-like peptide-1 receptor agonists (GLP-1s), particularly semaglutide and tirzepatide, have sparked
MIPS 2020 is here. Here are the highlights
Answers in Practice ... Faiza Wasif, MPH, is the AAD's practice management manager. Her column offers tips on an area she commonly receives questions about from members. ... By Faiza Wasif, MPH, April 1, 2020 Each month Dermatology World ... tackles issues "in practice" for dermatologists. This month Faiza Wasif,
What’s the latest on treating cutaneous dermatophyte infections in the era of Trichophyton indotineae?
Clinical Applications ... By Sylvia Hsu, MD, FAAD, March 1, 2025 In this month’s Clinical Applications column, DermWorld ... Editorial Advisory Workgroup member Sylvia Hsu, MD, FAAD, talks to Ananta Khurana, MD, Kabir Sardana, MD, and Anuradha Chowdhary, MD, about their JAAD ... paper, ‘ Clinico-mycological and therapeutic updates on
Itching to prescribe the right treatment for scabies: Topical permethrin or oral ivermectin?
Three weeks after confirming the diagnosis of crusted scabies on an HIV-positive patient, I started to scratch while driving in the parking lot at Cooper University Hospital. I didn’t give it much thought until the next day, when this stinging-itching sensation wouldn’t relent (interestingly the scratching felt soooo gooood). I
January 15, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / January 15, 2020 ... Which cosmeceuticals have proven clinical efficacy? DW Insights and Inquiries: Thoughts on hyaluronidase and The House of God Cancer death rate falls by largest one-year drop on
Advocacy Update Aug 5, 2025
The AADA recently joined members of the SUNucate Coalition in endorsing a bipartisan bill that would streamline the FDA review process of the effectiveness and safety of new ingredients for nonprescription sunscreens.
Impact Report — Vol 4, Issue 3
At the Academy, our number one priority is to support our members. To do that, we are consistently evaluating our initiatives and programs to ensure you are getting the most from your membership. See how we support you through advocacy, read about our success in positioning your expertise with the
Associate membership | AAD
Information about Associate membership in the American Academy of Dermatology. Learn about eligibility, the timeline, application requirements, dues and fees, and how to apply.
Advocacy Update Jan 27, 2026
The AADA urges Congress to back clinician-led data registries and relieve administrative burdens as it contemplates a successor to MIPS.
What's the fuss about fungus?
Dermatologist nail experts discuss the diagnosis and management of onychomycosis as well as increasing resistance to anti-fungal therapies. ... Feature ... By Allison Evans, Assistant Managing Editor, January 1, 2024 Onychomycosis (tinea unguium) represents the highest proportion of nail disorders seen in clinical practice. With long and often unappealing therapeutic
Summary of MIPS 2021 changes
Answers in Practice ... By Faiza Wasif, MPH, manager, practice management, February 1, 2021 Each month DermWorld ... tackles issues "in practice" for dermatologists. This month Faiza Wasif, MPH, the Academy’s Practice Management manager, offers a summary of MIPS changes in 2021. CMS released the final Quality Payment Program (QPP)
Advocacy Update Sept 23, 2025
The Academy joined more than 30 medical organizations expressing concerns to CMS about the process for reviewing and selecting quality measures in MIPS.
Impact Report — Vol 3, Issue 2
The AAD/A Impact Report isn’t just a chronicle of Academy wins for our members (although it is that, too), it’s an ongoing confirmation that we are listening to you, responding to your needs, and giving you the tools you require to grow in your profession.
Advocacy Update Oct 7, 2025
Despite the ongoing government shutdown, Medicare will continue processing and paying claims, and providers should not experience significant disruptions.
Intellectual property issues for dermatology practices
Legally Speaking ... Robert M. Portman, JD, MPP, is a health care attorney with Powers Pyles Sutter & Verville, in Washington, D.C. ... By Ben Tesdahl, JD, LL.M, Fernando Montoya, JD, and Robert M. Portman, JD, MPP, January 1, 2023 DermWorld ... covers legal issues in "Legally Speaking." This month’s
Trialing it out
In Practice ... Craig Leonardi, MD, from Central Dermatology in St. Louis, specializes in treatment of moderate to severe psoriasis and other dermatologic diseases. He is also an adjunct professor of dermatology at St. Louis University Medical School. ... By Victoria Houghton, assistant managing editor, July 2, 2018 Dermatology World
Scope of practice
Moving the needle ... By Victoria Houghton, Managing Editor, January 1, 2022 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. Non-physician clinicians are increasingly being incorporated into dermatology practices nationwide. One of the AADA’s top priorities is to
Advocacy Update Aug 26, 2025
The AADA joined the American Medical Association and other specialty and state societies to oppose the Ensuring Community Access to Pharmacist Services Act.
Advocacy Update Nov 18, 2025
President Trump signed a bill to reopen the government with an extension of the lapsed telehealth flexibilities until Jan. 30, 2026. See how the bill impacts dermatology.
CMS proposes to decrease physician payment in 2027
CMS released the proposed 2027 Medicare Physician Fee Schedule where dermatologists will see a significant payment decrease, underscoring the continued instability of the Medicare physician payment system. The AADA remains steadfast in securing meaningful Medicare physician payment reform.
Advocacy Update April 7, 2026
New Hampshire governor vetoed HB 349, which would have allowed optometrists to perform surgery using lasers.
Navigating MIPS 2026: A survival guide for dermatology practices
Answers in Practice ... By Olivia Barry, Manager, Practice Management, April 1, 2026 Each month, DermWorld ... tackles issues "in practice" for dermatologists. This month, practice management staff discuss navigating MIPS in 2026. CMS has released the rules for the MIPS program for 2026 and continues to encourage use of
A cold abscess remains a cold case: Multiple neonatal staphylococcal cold abscesses of the large folds
Healthy neonates presenting with cold abscesses in skin folds and growing methicillin-sensitive Staphylococcus aureus on culture may have “Multiple Neonatal Staphylococcal Cold Abscesses of the Large Folds.” With appropriate treatment, this benign disorder will not have any untoward sequelae.
MIPS 2026 FAQs
Get answers for frequently asked questions about MIPS. These resources include a MIPS/MACRA glossary, information on participation thresholds and deadlines, how to avoid the penalty, how to earn an incentive, and much more.
MIPS 2025 FAQs
Get answers for frequently asked questions about MIPS. These resources include a MIPS/MACRA glossary, information on participation thresholds and deadlines, how to avoid the penalty, how to earn an incentive, and much more.
Advocacy Update Aug 19, 2025
The AADA met with Cigna to review its (E/M) Coding and Accuracy policy, which is set to target physicians who frequently report Level 4 and 5 codes starting Oct. 1.
Advocacy Update May 19, 2026
The Delaware Academy of Dermatology urged members of the Delaware Senate Legislative Sunset Committee to oppose SB 295, which would significantly expand the scope of practice of aestheticians into the practice of medicine.
Adjunct membership | AAD
Information about Adjunct membership in the American Academy of Dermatology. Learn about eligibility, the timeline, application requirements, dues and fees, and how to apply.
Advocacy Update Apr. 8, 2025
AADA asks FDA to continue collaboration on AI-enabled medical devices guidance.
The bigger picture
AAD’s Clinical Image Collection furthers knowledge of treating all skin tones. ... Feature ... By Megan Bennett, Staff Writer, February 1, 2026 The appearance of several common skin conditions and diseases vary depending on patients’ skin color. However, overwhelmingly, clinical images in dermatologic literature and other professional educational resources represent
Turning our attention to melanoma risk in Turner syndrome
Patients with Turner syndrome have an increased risk of melanoma, possibly related to the number of nevi. The use of human growth hormone may contribute to the appearance of a larger number of acquired melanocytic nevi. Patients with Turner syndrome should be routinely screened for melanoma and practice standard sun
Lecturing about measles?
From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, January 1, 2020 Why would a dermatologist lecture about measles? Several years ago, I put together a grand rounds talk titled, "Measles: will you know it when you see it?" Like most
We live and work within a broad, intertwined community
From the President ... Dr. Olbricht served as Academy president from March 2018 to March 2019. ... By Suzanne Olbricht, MD, August 1, 2018 It’s August, which means summer vacations, cookouts, and sunscreen sunscreen sunscreen. While the dog days of summer can be a great time to relax and catch
Advocacy Update May 6, 2025
The AADA continues engaging CMS on revising CLIA laboratory director requirements
Advocacy Update Sept 30, 2025
With the potential failure of Congress to pass a funding package, the federal government will face a shutdown at midnight on Sept. 30.
Advocacy Update Nov 25, 2025
A recent report by the Office of the Inspector General found that dermatologists are appropriately using Modifier 25 the vast majority of the time. The report was compiled in response to scrutiny by CMS of how dermatologists use the modifier. In 9 out of 10 instances sampled, dermatologists are following
Advocacy Update Jan 20, 2026
The AADA nominated and CMS selected AADA board member Alina Bridges, DO, FAAD, to serve as an expert on CMS’s Medicare CLDT Advisory Panel.
Intermediate and complex repair
Access valuable Academy update on codes that have been revised for 2020, particularly those associated with intermediate and complex repairs.
Dermatology is a taxing specialty
From the Editor ... Dr. Heymann is the physician editor of ... DermWorld . ... By Warren R. Heymann, MD, FAAD, April 1, 2026 April 15 may be Tax Day, but every day is taxing for dermatologists. This issue of ... DermWorld focuses on making practice less taxing administratively and
More unintended consequences
From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, FAAD, January 1, 2022 The law was presumably well intended: Patients deserve access to their health information, and to the uninitiated, it makes sense that this should happen immediately. After all, why
The neutrophil-to-lymphocyte ratio in cancer: Beauty in simplicity
The world was stunned and saddened on January 28th, 1986 when the Space Shuttle Challenger exploded. Six months later, during the meeting of the Rogers Commission analyzing the disaster, the famed physicist Richard Feynman demonstrated how O-rings lost their resilience. By placing the sample material in ice water, he proved
New AAD research grant focuses on understudied hair disorders
In this DermWorld Weekly interview, Maria K. Hordinsky, MD, chair of the Academy’s Wen Cy Pres Award Workgroup, and Susan C. Taylor, MD, member of the Wen Cy Pres Award Workgroup, highlight a new and significant opportunity for members to contribute to research for hair disorders, particularly those disorders impacting
2025 AADA Legislative Conference: FAQs
Review Legislative Conference FAQs to get answers to your questions. Learn about what the conference is, when and where it occurs, how you can register, and more.
Advocacy Update May 13, 2025
The Senate introduces the AADA-endorsed Medicare Patient Access and Practice Stabilization Act
Advocacy Update Oct 14, 2025
The Academy continues to monitor the current government shutdown and its impact on dermatologists. The Medicare program is covering and paying for physician services but will not cover telehealth visits.
Advocacy Update Oct 21, 2025
CMS reversed its decision to hold Medicare reimbursement payments. CMS has since indicated it will be processing and issuing payments in a timely manner.
Advocacy Update Feb. 25, 2025
As a direct result of AADA’s advocacy, Regence Blue Cross Blue Shield rescinded its modifier 25 payment reduction policy.
Advocacy Update April 21, 2026
As a direct result of AADA advocacy in collaboration with the American Medical Association (AMA), Michigan State Medical Society (MSMS), Michigan Dermatology Society (MDS), Blue Cross Blue Shield of Michigan (BCBSM) is pausing implementation of its modifier 25 payment reduction policy.
Eruptive nevi: Trying to connect the dots
Eruptive nevi are striking – they may appear after a variety of disorders, including Stevens-Johnson/toxic epidermal necrolysis, primary blistering diseases, trauma, immunosuppression (from disease or iatrogenically-induced), PUVA therapy, or idiopathically. There are also several reports in the literature for eruptive Spitz nevi and blue nevi.
Fighting fungi
With increasing resistance to antifungal therapies, here’s what dermatologists need to know about managing dermatophytosis. ... Feature ... By Allison Evans, Assistant Managing Editor, June 1, 2024 A patient presents with widespread, pruritic, scaly, and erythematous plaques of what appears to be tinea corporis. It may be routine to prescribe
The nexus of VEXAS syndrome
Read the December 1, 2021 DermWorld Insights and Inquiries on VEXAS syndrome.
The alphabetization of lymphomatoid papulosis: Focus on “F”
The 50th anniversary of Warren Macaulay’s seminal description of lymphomatoid papulosis (LyP) is approaching.
It takes more than a day
From the President ... Dr. Kaufmann served as Academy president from March 2022 to March 2023. ... By Mark Kaufmann, MD, FAAD, February 1, 2023 It’s the start of a new year and naturally, I find myself reflecting on the ups and downs of the last 12 months. There were
Advocacy Update Jan. 14 2025
The 119th Congress started its new session and commenced with leadership elections in the House.
Advocacy Update Feb 24, 2026
The AADA led a joint meeting with the Food and Drug Administration to safeguard patient access to patch testing.
Advocacy Update March 10, 2026
The AADA and the Dermatologic Medicare Contractor Advisory Committee asked 5 Medicare Administrative Contractors to update the new guidelines for patch testing.
Advocacy Update Dec 16, 2025
The AADA applauded the FDA for proposing to permit use of a new sunscreen ingredient, bemotrizinol (BEMT).
Advocacy Update Apr. 1, 2025
HHS announced a major restructuring to reduce full-time employees, consolidate divisions, and decrease regional offices.
Advocacy Update Apr. 22, 2025
The AADA urges CMS to amend CLIA lab director requirements.
The Academy’s impact
Through AAD humanitarian programs, we carry out our commitment to educate the public about healthy skin, hair, and nails in an effort to motivate them to take positive action in improving their quality of life, and in the case of skin cancer, save lives. Additionally, we recognize the importance our
Vascular Ehlers-Danlos syndrome: From rupture to rapture?
Read the February 16, 2022 DermWorld Insights and Inquiries on Vascular Ehlers-Danlos syndrome.
Can oral ivermectin cure pediatric periorificial dermatitis? It mite!
Ask any child when how long it is until their next birthday and they can usually give you a precise answer. If I’m treating a child with periorificial dermatitis (POD, also granulomatous POD or perioral dermatitis), I can’t wait until they turn 8, so I can prescribe doxycycline.
Keeping abreast of the expanding literature of implant-associated Anaplastic Large Cell Lymphoma (ALCL)
Silicone gel implants were removed from the US market in 1992 because of health concerns, only to be reintroduced in 2006, with the provision for increased surveillance of health outcomes. I was under the (apparently mistaken) impression that the FDA put the brouhaha of a potential association of silicone
Could wart immunotherapy open a therapeutic window for congenital nevi at risk for melanoma?
Two of the most vexing problems pediatric dermatologists face is treating recalcitrant warts and managing large congenital nevi.
April 8, 2026
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 8, 2026 ... Does oral spironolactone improve acne in women? DermWorld What’s Hot: mRNA COVID vaccine and immune checkpoint inhibitor response Herbal medicines for psoriasis Efficacy of PDT and fractional
Advocacy Update Jun 10, 2025
AADA President Susan Taylor, MD, FAAD participated in the House Republican Doctors Caucus roundtable in discussions on Medicare physician payment reform.
Advocacy Update March 31, 2026
The AADA urged the FDA to reconsider its withdrawal of the proposed indoor sunlamp regulation and finalize restrictions on youth access.
Triskaidekaphobia legitimized: Fatal Factor XIII deficiency
Read the April 12, 2023 DermWorld Insights and Inquiries on triskaidekaphobia legitimized and fatal factor XIII deficiency.
The appeal of molecular medicine for the peeling skin syndrome
This may not be the most appropriate dermatologic admission, but as a child, I really enjoyed peeling away my post-sunburn desquamation. What joy ensued when it came off with glistening new skin underneath! Of course, I’m from the “now we know better” generation – this should never happen in 2018
A string of (clinical) pearls about drug-induced linear IgA disease
The late sage Wallace Clark taught me that once a diagnosis is secured, thinking ceases. Admittedly in cases of drug-induced linear IgA dermatosis (DI-LAD) that I have encountered (due to vancomycin), once the diagnosis was suspected and confirmed, I never gave it too much thought. Recent findings in the DI-LAD
Research suggests connection between hair loss in women and other diseases
Board-certified dermatologist discusses common types of hair loss seen in women with darker skin tones NEW ORLEANS (March 17, 2023) — Hair loss in women can be emotionally devastating and may negatively impact quality of life, and new research suggests that it can also be associated with having other common
Social media skin care trends: Dermatologists reveal the facts
Board-certified dermatologists provide tips for healthy skin ROSEMONT, Ill. (Oct. 29, 2024) — With the growing popularity of beauty influencers and viral skin care routines, social media is playing an integral role in shaping how people care for their skin. Popular trends like the glass-skin look, the Russian manicure, and
Caveat mTOR revisited: Neurofibromatosis
Targeting the MAPK/ERK and PI3K/AKT/mTOR pathway has led to the use of topical sirolimus for neurofibromas and oral selumetinib for children with plexiform neurofibromas.
Taking woolly hair to heart
Read the October 27, 2021 DermWorld Insights and Inquiries on woolly hair.
Striving to avoid an amebic nightmare: Recognizing cutaneous Balamuthia mandrillaris infection
Dermatologists should be familiar with cutaneous infection by the ameba Balamuthia mandrillaris. Although rare, this is considered an emerging disease worldwide. Early recognition and treatment of cutaneous disease may decrease the risk of death from granulomatous amebic encephalitis.
I never wanted chaperones — until now
Learn more about I never wanted chaperones — until now at aad.org
The specialty’s power comes from our unified voice.
From the President ... Dr. Cronin served as Academy president from March 2023 to March 2024. ... By Terrence A. Cronin Jr., MD, FAAD, October 1, 2023 We are a small specialty compared to others in the house of medicine. However, we have an outsized voice because we are extremely
The power of state advocacy
From the President ... Dr. Hruza served as Academy president from March 2019 to March 2020. ... By George Hruza, MD, MBA, November 1, 2019 When you think of advocacy, what do you think of? Capitol Hill and Congress? CMS and the FDA? If so, you’re not wrong. Many facets
A potentially life-threatening association of autoimmune blistering disease we bloody well need to be aware of: Acquired hemophilia A
I have been treating patients with autoimmune bullous disorders for nearly four decades. The diseases’ vagaries and associations always astound me.
Can steroids extinguish the fire of erythromelalgia?
The burning sensation of erythromelalgia is matched by a burning desire to help these patients. According to Tang et al: “This rare and debilitating disorder was first reported and named “erythromelalgia” according to its main symptoms (erythros-red, melos-limbs, algos-pain) by Mitchel in 1878.
September 18, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / September 18, 2024 ... Spironolactone for alopecia: Blood pressure changes DermWorld Insights and Inquiries : The appropriate dermatologic response when considering the capillary malformation-arteriovenous malformation syndrome — Fast flow to referral
June 27
Learn more about June 27 at aad.org
December 17, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Dec. 17, 2025 ... Antiandrogen therapy for female pattern hair loss DermWorld Insights and Inquiries : Long COVID has a lot of nerve Hidradenitis suppurativa treatment during pregnancy, lactation The role
Advocacy Update Jun 3, 2025
The AADA continues discussions with CMS advocating for revisions to recent CLIA requirements to ensure that all board-certified dermatologists are approved as lab directors of dermatology labs.
Advocacy Update Jun 17, 2025
The Rhode Island Dermatology Society (RIDS) urged legislators to delay action and continue working on medical spa legislation.
Advocacy Update Jun 24, 2025
The Senate Finance Committee released its draft tax and health care legislation as part of the budget reconciliation process.
Advocacy Update Jul 29, 2025
AADA Vice President-elect Larry Green, MD, FAAD, represented dermatologists on behalf of SkinPAC at an event in Washington, D.C., with his member of Congress, Sarah Elfreth (MD-03) to urge support for Medicare physician payment reform.
Advocacy Update Oct 28, 2025
After weeks of confusion, CMS allowed MACs to begin processing most claims with dates of service on or after Oct. 1, 2025.
Advocacy Update Nov 11, 2025
The AADA joined over 30 other medical specialty groups demanding relief from the CMS efficiency adjustment in the 2026 Medicare Physician Fee Schedule final rule.
Advocacy Update Jan. 21 2025
On Jan. 16, the Medicare Payment Advisory Commission recommended linking 2026 Medicare physician payment update to the growth in the cost of providing care, minus one 1 percentage point.
Advocacy Update Feb 10, 2026
The AADA, in collaboration with the allergy specialty societies, demanded that the FDA preserve patient access to high-quality patch testing haptens.
Advocacy Update Jan 13, 2026
The AADA urges New York to pass legislation requiring medspas to clearly disclose that they are not licensed to perform medical procedures.
Reporting Quality for MIPS
The tracking of quality measures and the performance of improvement activities can help to lead to improved outcomes in patient care.
Melanoma clinical guideline
Access information on the Academy's guidelines of care for melanoma. This page provides convenient, at-a-glance highlights from the full guidelines, providing dermatologists with the most important clinical information.
Slivers of skin may diagnose silver hair syndromes
Simple tests may help distinguish the rare silver hair syndromes (SHS): Chediak-Higashi (CHS) and Griscelli (GS).
Waiting for Wong
The Wong variant of dermatomyositis was originally described by O’Leary during the Eisenhower administration (1953) and named for Wong during Nixon’s tenure (1969). I have been involved with dermatology since Carter’s term in office (1979). Since that time (Reagan, Bush, Clinton, Bush, Obama) I have yet to see a case
Moving forward
The Academy scored big wins for dermatology in 2021, but the work to ensure safe patient access to dermatologic care continues ... Feature ... By Ruth Carol, Contributing Writer, January 1, 2022 Every year, the American Academy of Dermatology Association (AADA) tackles a long list of federal and state legislative
What are treatment recommendations for managing CCCA?
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, August 1, 2024 In this month’s Clinical Applications column, DermWorld ... Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Susan
Is dyshidrosiform pemphigoid really anti-p200 pemphigoid?
Dyshidrosiform pemphigoid (DP) was initially reported in a 72 year-old man with large, tense bullae on the plantar aspect of his feet, with some lesions on an erythematous base. He also had an “ill-defined papular eruption” of the trunk and an erosion of the posterior pharynx. Routine microscopy demonstrated a
Crystallizing thoughts about crystalglobulinemia
Every resident asks me if and when they will become confident about their level of knowledge. My answer is simple and consistent – never. This perception was reinforced by perusing the outstanding review of cutaneous paraprotein deposits by Alegría-Landa et al, that included a discussion of “crystalglobulinemia” (1); I was
Dupilumab’s conjunctivitis conundrum
Having worn glasses since kindergarten, and being virtually helpless without them, I am particularly sympathetic to patients with eye disorders.
Advocacy Update Nov 4, 2025
Dermatologists will see a slight payment increase for the first time in five years, according to the final 2026 Medicare Physician Fee Schedule (PFS) published on Oct. 31.
Advocacy Update Feb. 11 2025
The AADA President sent out a message encouraging members to urge their representative to cosponsor new Medicare legislation.
Advocacy Update Feb 17, 2026
The AADA submitted a statement highlighting the need for Medicare physician payment reform to the Senate Special Committee on Aging.
Advocacy Update Mar. 11, 2025
The AADA joined the American Medical Association, American College of Radiology and 92 other physician and non-physician groups called on congressional leadership to address Medicare reimbursement cuts.
Advocacy Update Apr. 29, 2025
The AADA urges CMS to address No Surprises Act burden requirements.
Improvement activities (15%)
Access Academy resources on the Improvement Activities reporting category, which makes up 15% of a dermatologist's MIPS score. Learn about the reporting requirements and the distinction between medium- and high-weighted activities. Clinicians are rewarded for care focused on care coordination, beneficiary engagement, and patient safety.
Truth in advertising
... Alabama Licensure identification Board certification (BC) Derm-specific BC Misleading advertising Licensees are prohibited from using a title in which in any way represents such person as engaged in the practice of any branch of the healing arts for which such person holds no license. ... n/a ... n/a
COVID-19 and dermatology
What have we learned about the cutaneous manifestations of the virus and the vaccines? ... Feature ... By Emily Margosian, Assistant Editor, December 1, 2021 While the immediate and long-term effects of COVID-19 on the human body are still being studied, new research regarding the cutaneous manifestations of the virus
Emerging diseases registry
This survey is for all health care professionals taking care of patients with either (a) suspected or (b) confirmed drug-resistant dermatophytosis that you wish to report.
Differentiating lichen planopilaris from chronic cutaneous lupus may be as easy as 1,2,3 (actually CD123)
My last dermatopathology case of the week was that of a woman with scarring alopecia, which was clearly well advanced. Hardly any follicles remained, and on one section there was a small follicular unit with a peri-infundibular mononuclear infiltrate and slight vacuolar alteration of the follicular epithelium. I signed the
Dermatologists cannot be lax about acquired cutis laxa
From the time I was a medical student, I have always been fascinated by the “little old man” appearance of patient with cutis laxa (CL).
New CDC treatment guidelines for sexually transmitted infections
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, May 1, 2022 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Kimberly A. Workowski,
Why you should hear about the red ear syndrome
Read the July 22, 2020 DermWorld Insights and Inquiries on red ear syndrome.
Exchanging plasma exchange for a novel approach: The potential of FcRn antagonists in dermatologic autoimmune disease
FcRn antagonists, currently approved for treating myasthenia gravis, show potential for treating pemphigus and other autoimmune diseases.
Coding and documentation — Your best defense
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Senior Manager, Coding and Reimbursement, October 1, 2025 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . Accurate and thorough documentation in the medical
Getting to the heart of neonatal lupus erythematosus
Read the July 21, 2021 DermWorld Insights and Inquiries on getting to the heart of neonatal lupus erythematosus.
What are keratoacanthomatous lesions of the legs in mature women?
I have an increasing number of patients asking me questions about proliferating keratoacanthoma-like lesions on their shins. “Why am I getting these? Are they cancer? Why do more of them appear after surgery?”
Cannabinoids may elevate therapy for connective tissue diseases to a higher level
Medical “reefer madness” is taking hold in the United States with approximately 10% of cannabis users utilizing it for diverse medical conditions, including dermatologic disorders such as pruritus and atopic dermatitis. To date, at least 28 states allow for the use of medical cannabis. (1)
Pediatric dermatology
Finding Joy in pediatric phototherapy Congenital Juvenile Xanthogranulomas: Born To Be Wild (But Ultimately Mild) Sophie’s choice: Assessing atypical Spitz tumors in the molecular era The real jigsaw puzzle of the Brooke-Spiegler Syndrome: Translating the molecular biology to therapy Sirolumus’s merit for the Kasabach-Merritt phenomenon A future therapeutic Harlequin Romance?
Trichophyton rubrum resistant to terbinafine
T. rubrum, a dermatophyte fungus, is the most common cause of dermatophytosis worldwide. Cases of terbinafine-resistant T. rubrum are increasingly being reported worldwide and in the United States.
Improvement activities (15%)
Access Academy resources on the Improvement Activities reporting category, which makes up 15% of a dermatologist's MIPS score. Learn about the reporting requirements and the distinction between medium- and high-weighted activities. Clinicians are rewarded for care focused on care coordination, beneficiary engagement, and patient safety.
Calcineurin inhibitors under occlusion – I could’ve had a V8!
I have used topical steroids under occlusion for as long I have been in dermatology. What a fabulous maneuver this is for difficult to treat dermatoses such as lichen simplex chronicus, recalcitrant psoriasis, or hypertrophic lichen planus, etc.
Yom Kippur and the physician payment Sunshine Act
Yom Kippur, the Jewish day of atonement, is upon us. It is Judaism’s most sacred holiday. It is a day of fasting and prayer to atone for sins of the past year. According to traditional teachings, a person’s fate is written in the Book of Life on Rosh Hashanah (the
Dyeing for a “new” topical agent for psoriasis? Think indigo
Despite the magnificent revolution of biologics for psoriasis, topical agents remain the cornerstone of treatment, either alone, or in combination with phototherapy or systemic treatments.
AAD EpiDerm Awards 2021
From the President ... Dr. Tomecki served as Academy president from March 2021 to March 2022. ... By Kenneth Tomecki, MD, FAAD, January 1, 2022 "Lights, camera, action…" Now is that time for the Academy EpiDerm awards which recognize significant achievement in the specialty during the last year or two
It has been an incredible journey.
From the President ... Dr. Hruza served as Academy president from March 2019 to March 2020. ... By George Hruza, MD, MBA, March 1, 2020 It boggles the mind how quickly 12 months can pass. As I sit here thinking back on the past year serving as your Academy president,
Moving in to first place: Antimalarials for treating generalized granuloma annulare
At a University of Pennsylvania Duhring Conference years ago, an inquiring dermatologist asked Jim Leyden how he knew the patient had generalized granuloma annulare (GGA). “It’s easy” Jim replied. “It just looks like somebody poured a box of Cheerios on them, and they stuck”. I have never seen a patient
May 12, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 12, 2021 ... Telogen effluvium diagnosis during the COVID-19 pandemic DermWorld Insights and Inquiries : For patients with erythropoietic protoporphyria the tide has come in Derm Coding Consult : How
February 22, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 22, 2023 ... How effective are field treatments for actinic keratosis? DermWorld Insights and Inquiries : Saving face — The importance of recognizing facial discoid dermatosis A systematic review of
June 15, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 15, 2022 ... FDA approves first systemic treatment for alopecia areata DermWorld Insights and Inquiries : Aluminum can cause allergic contact dermatitis — Allergen of the Year 2022 DermWorld Young
January 8, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / January 8, 2020 ... FDA’s biotin warning: Was it enough to educate physicians, patients about the risks? DW Insights and Inquiries : Dupilumab’s growing pains 2020 kicks off with revised ICR
Advocacy Update May 20, 2025
House committees advanced the budget reconciliation bill, which included a provision to reform the current Medicare physician payment cuts and tie annual updates to medical inflation.
Advocacy Update Jan. 7 2025
Congress failed to stop 2025 Medicare payment cuts further fueling AADA members to contact their federal legislators.
Advocacy Update Jan. 28 2025
The Academy asked the Trump Administration to work with Congress and CMS to prioritize Medicare payment reform and develop a solution to stabilize the physician payment system.
Advocacy Update March 3, 2026
The AADA has actively engaged CMS around training requirements for dermatologists performing SRT.
Advocacy Update March 17, 2026
The AADA continues to encourage the FDA to implement the updated changes to the iPLEDGE program and continues to advocate for changes to Medicare Local Coverage Determinations (LCDs) governing the use of superficial radiation therapy.
Advocacy Update March 24, 2026
The Academy’s recent statement on the FDA’s withdrawal of a proposed rule on sunlamp regulation drove media coverage, encouraging the FDA to reconsider this action.
Advocacy Update Mar. 25, 2025
AADA backs dermatologists on CLIA lab director requirements.
Advocacy Update Apr. 15, 2025
Leading medical societies call for action on Medicare physician payment reform.
Compounding toolkit
Learn about compounding and use the Academy's free tool to determine whether particular medicines can be compounded. Due to a 2016 FDA rule, medicines that may have been compounded by a compounding pharmacy in the past for office stock may no longer be available. Dermatologists should seek to understand the
Side gig
Go to AAD Home ... Go to AAD Home ... Menu ... What can physicians do in addition to clinical services, and how do you get started? ... What can physicians do in addition to clinical services, and how do you get started? ... By Emily Margosian, assistant editor While
This month's news from across the specialty
What's hot ... October 1, 2020 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... ED COWEN, MD Why do a small percentage of young and apparently healthy patients with COVID-19 develop life-threatening infection or a Kawasaki syndrome-like
Coming to terms with Louis Brocq and his diagram: Pityriasis lichenoides 2018
As a first-year dermatology resident in 1980, I struggled with the concept of parapsoriasis. In trying to conceptualize the process, I recall being distressed after seeing Louis Brocq’s diagram from his classic paper, “Les parapsoriasis,” published in 1902 — Would I ever understand this? What is the relationship to
Keeping dermatologists in the driver’s seat with step therapy reform
Moving the needle ... By Victoria Houghton, Managing Editor, March 1, 2023 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. Step therapy protocols interfere with patient care and create unwanted burdens on dermatology practices. Thanks to the AADA’s
So many questions. So little time.
Experts offer best practices on efficiently addressing patients’ questions about sunscreen. ... Feature ... By Andrea Niermeier, April 1, 2023 Aisles of products, numerous social media top 10 lists, and abundant information on the internet: Consumers can be quickly overwhelmed with sunscreen questions related to types, usage, and safety —
Tennessee legislation increases transparency
Tennessee Gov. Bill Lee (R) signed legislation limiting the use of medical specialty titles in advertisements.
Leishmania episode 1a: attack of the clones
Read the February 10, 2021 DermWorld Insights and Inquiries on Leishmania.
This month’s news from across the specialty
What’s hot ... March 1, 2025 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Bryan Carroll, MD, PhD, FAAD "Greatest Greetings of Todays Dr. Carroll! Taking this opportunity, we would like to cordially invite you to contribute
Memories of pneumocystis pneumonia and thoughts of prophylaxis
My childhood friend Alan was a rotating surgical resident at Methodist Hospital in Houston when he saw my brother Andrew in the ICU. “Warren, I think you better come here ASAP.” Thirty-six years ago, the first sight of my severely jaundiced brother, with nasal necrosis (presumably mucormycosis), and a chest
March 19, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 19, 2025 ... Association between actinic keratosis treatments and use of antihypertensives? DermWorld Insights and Inquiries : Mastering dermatology Laser and energy treatments for acne scarring Efficacy of upadacitinib vs.
Advocacy Update Jul 15, 2025
In case you missed it, Congress passed budget reconciliation legislation that included a one-year 2.5% increase for the 2026 Medicare Physician Fee Schedule to account for sustained cuts as Congress continues to work toward long-term payment reform.
LIDA* rose the insulin requirement
Read the April 14, 2021 DermWorld Insights and Inquiries on localized insulin-derived amyloidosis.
Teledermatology workflow for small practices
Use the workflow below to help you implement or improve your teledermatology operations. This version is designed for solo or small practices.
Peace of mind
Finding the right insurance coverage to protect your practice. ... Feature ... By Andrea Niermeier, Contributing Writer, September 1, 2024 While the adage goes, "By failing to prepare, you are preparing to fail," this simple witticism has grown complicated for dermatologists looking to protect themselves, their practices, and their patients.
2024 Allergen of the year: Sulfites
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, April 1, 2024 In this month’s Clinical Applications column, DermWorld ... Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Erin
February 16, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 16, 2022 ... A review of calcipotriol plus 5-fluorouracil for actinic keratosis DermWorld Insights and Inquiries : Vascular Ehlers-Danlos syndrome: From rupture to rapture? Delayed complications for FDA-approved HA dermal
Key messaging in social media about acne
By communicating these key messages on acne, you can help position the specialty while increasing your credibility and raising the profile of your practice. These include the causes of acne, how to care for it, and treatment options.
A sweeter approach to treating scleroderma?
We’re like licorice. Not everybody likes licorice, but the people who like licorice really like licorice – Jerry Garcia. Patients with scleroderma may learn to love licorice.
Scar solutions
Experts discuss current approaches to scar management. ... Feature ... By Emily Margosian, Assistant Editor, January 1, 2025 Every scar has a story. However, for millions of people worldwide, scars may negatively impact their quality of life, causing psychological distress along with physical discomfort. ... While therapeutic approaches to treat
A shot in the dark
Read the March 10, 2021 DermWorld Insights and Inquiries on COVID arm.
2024 MIPS update
What dermatologists need to know about this year’s MIPS reporting. ... Feature ... By Allison Evans, Assistant Managing Editor, May 1, 2024 "If you provide Medicare services, MIPS is a must when it comes to your reimbursement," said Florida dermatologist Shawna Flanagan, MD, FAAD, member of the Academy’s Practice Management
This month’s news from across the specialty
What’s hot ... March 1, 2026 In this monthly column, members of the DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty. Harry Dao Jr., MD, FAAD Injectable biologics remain the gold standard for achieving optimal clinical responses in psoriasis, but fear of injections leads many
What is the economic burden of drug utilization management?
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, January 1, 2022 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Scott Howell, MD,
CMS releases third and fourth quarter NCCI edits
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Coding & Reimbursement, January 1, 2022 Academy coding staff address important coding topics each month in DermWorld Coding Consult. ... Read more Derm Coding Consult articles . CMS has released its third and fourth quarterly
August 16, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 16, 2023 ... Off-label use of calcineurin inhibitors for dermatologic conditions DermWorld Insights and Inquiries : Diagnosing nail unit melanomas at a faster clip What are risk factors for developing
July 9, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 9, 2025 ... Do at-home LED devices for acne work? DermWorld Insights and Inquiries : Standard postoperative wound care practice may be all wet Academy mourns the passing of Ronald
Advocacy Update Jul 1, 2025
The Senate advanced their version of reconciliation tax and health legislation, which included a temporary one-year, 2.5% bump to the physician fee schedule for 2026.
Myths and facts about human trafficking
There are many misconceptions about the nature of human trafficking which can compromise a dermatologist’s ability to recognize it during a patient visit.
A seasoned approach to treating the “salt and pepper” dyspigmentation of systemic sclerosis
Read the Feb. 8, 2023 DermWorld Insights and Inquiries on surgeons' primary intention to reduce secondary infection.
Selling a practice resources
Explore these related resources for selling a practice. These include a variety of articles from Dermatology World, an overview of the types of dermatology practice ownership, and the five largest private equity-backed groups.
Learning module: Genetic skin diseases
The purpose of the genetic skin diseases learning module is to help develop a clinical approach to the evaluation and initial management of patients presenting with genodermatoses.
Mohs Surgery Appropriate Use Criteria (AUC) app
Learn about the Academy's Mohs Surgery Appropriate Use Criteria (AUC) app. With the app, you can easily and systematically determine when Mohs surgery is most appropriate for your patients from your mobile device, right at the point of care.
October 24
Learn more about October 24 at aad.org
Weighing in on glucagon-like peptide-1 receptor agonists in dermatology
Glucagon-like peptide-1 (GLP-1) receptor agonists are now approved for weight loss, which may benefit dermatoses associated with excess weight. Dermatologists should be familiar with the potential adverse effects and benefits of these drugs.
Pathway to reducing medical errors
Although the overall error rate may be low, there are specific areas and opportunities to further reduce errors in the diagnostic pathway. Being vigilant and recognizing steps prone to errors facilitates detecting errors before any potential harm comes to the patient.
Key messages for social media about hair loss
By communicating these key messages on hair loss, you can help position the specialty while increasing your credibility and raising the profile of your practice. Review key messages on causes of hair loss, the psychosocial impacts, and treatment options.
The changing face of care
DermWorld discusses digital pharmacies and direct-to-consumer (DTC) teledermatology platforms. ... Feature ... By Ruth Carol, Contributing Writer, February 1, 2023 Patients have more ways than ever to obtain medications and "care" to treat dermatologic conditions as digital pharmacies and direct-to-consumer (DTC) teledermatology websites continue to proliferate. First and foremost, these
Ready to launch
Academy HAIR Grants enable new research on hair loss and skin of color ... Feature ... By Jan Bowers, Contributing Writer, May 1, 2022 A nearly $1.5 million windfall from a class action lawsuit is enabling intensive, multifaceted research of traditionally understudied aspects of hair disorders afflicting diverse populations and
Not just scratching the surface
Experts share insights on managing neuropathic itch. ... Feature ... By Heidi Splete, Contributing Writer, October 1, 2026 Most itching is temporary, caused by an insect bite, allergies, or dry skin due to weather or other irritants. By contrast, the distinct condition of neuropathic itch starts below the skin, a
Skin cancer fact sheet
Find facts and statistics for reporting about skin cancer.
23andDermatology
Go to AAD Home ... Go to AAD Home ... Menu ... What are the dermatologic implications of direct-to-consumer DNA tests? ... What are the dermatologic implications of direct-to-consumer DNA tests? ... By Emily Margosian, assistant editor Spit, swab, drop DNA in the mail. Since genetic tests were first offered
This month's news from across the specialty
What's hot ... June 1, 2021 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Bryan Carroll, MD, PhD The debate over the curative benefit of radiotherapy for aggressive cutaneous invasive squamous cell carcinoma continues. The inflection point
This month’s news from across the specialty
What’s hot ... June 1, 2022 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Bryan Carroll, MD, PhD, FAAD A recent study compared lipidomes and transcriptomes of single cell dermal fibroblasts to explore the determinants of cell
I have moved. How do I update my contact information with the Academy?
Asked and Answered ... March 1, 2023 AAD members can conveniently update their contact information at any time by visiting account.aad.org and selecting the ‘My Profile’ tab from the menu below. ... For additional assistance, please contact the Member Resource Center at ... mrc@aad.org or 866-503-7546. ... Looking for more
FAQs: Interoperability and patient access
Get your questions on the information blocking rule answered in this FAQ. Info blocking is a complex subject, but this page answers the most commonly asked questions.
Congenital juvenile xanthogranulomas: Born to be wild (but ultimately mild)
Congenital juvenile xanthogranulomas usually appear early in life, although they may occur in adults.
Key messages when communicating about skin cancer
By communicating these key messages on skin cancer, you can help position the specialty while increasing your credibility and raising the profile of your practice. Skin cancer is the most common cancer in the United States. These are core messages to urge patients to seek screening.
A novel sebum inhibitor for acne vulgaris: A slick maneuver
What a pleasure it is to think about a novel treatment for acne! Honestly, have you gotten excited learning that the “same old, same old” is now available in a cloth or foam?
Of every possible solution for elastosis perforans serpiginosa, fractional carbon dioxide laser may be the best
My initial attraction to dermatology, which still offers great appeal, is the challenge and joy of differential diagnosis and clinical-pathologic correlation. I learned quickly, however, that patients don’t want to be interesting – they want a specific diagnosis for one reason only – to get the right treatment, preferably curative.
August 17, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Aug. 17, 2022 ... Do dietary exclusions improve atopic dermatitis? DermWorld Insights and Inquiries : Promising therapeutic developments for cutaneous lupus erythematosus — Interfering with interferon Derm Coding Consult : Dermatology
Payer advocacy: Prior authorization
The Academy advocates that prior authorization determinations should be standardized, and the speed of determination should be quantified and minimized. Unduly delays and poorly designed prior authorization protocols can cause irreparable harm to patients.
Medical vs. cosmetic dermatology: Who is doing what?
Facts at your Fingertips ... By Emily Margosian, assistant editor, January 1, 2019 Despite ongoing discussion about the role of cosmetics in the specialty, data from the 2017 AAD Practice Profile Survey indicate that medical dermatology remains the primary focus of dermatology practitioners across all types. However, dermatologists spend the
Life insurance 102: Five success factors when using permanent life insurance
Money Matters ... David B. Snyder, JD, CLU ... ® ... , is an attorney, author, and financial advisor at the wealth management firm OJM Group. He covers financial issues for dermatologists in this quarterly ... Dermatology World column. ... By David B. Snyder, JD, CLU, September 2, 2019 In
What's hot?
What's hot ... August 27, 2019 In this monthly column, members of ... Dermatology World 's Editorial Advisory Workgroup identify exciting news from across the specialty. ... Bryan Carroll, MD, PhD ... Identifying the origin of head and neck squamous cell carcinoma of an unknown primary can inform prognosis and
Tofacitinib: A JAK inhibitor of all trades
Learn more about Tofacitinib: A JAK inhibitor of all trades at aad.org
Injecting ideas (and therapies) in digital mucous cysts
Digital mucous (myxoid) cysts are often associated with osteoarthritis. Multiple therapeutic maneuvers may be utilized, but the best results remain with surgical excision.
March 17, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 17, 2021 ... COVID-19 in melanoma patients DermWorld Insights and Inquiries : Hoops and happiness — Having the courage to take a shot DermWorld Young Physician Focus : Forging ahead
Skin conditions by the numbers
Find facts and statistics for reporting about dermatology and dermatologic conditions.
MIPS reporting in 2018
In Practice ... Rachna Chaudhari is the AAD's practice management manager. Her column offers tips in response to common member questions. ... By Rachna Chaudhari, MPH, director of practice management, February 1, 2018 After requiring dermatologists to report one measure one time in 2017 to avoid a 4% penalty in
A tale of two disorders of hypopigmentation: The potential role of Cutibacterium acnes dysbiosis in progressive macular hypomelanosis and lichen striatus
The human (and skin) microbiome is intricately involved in health and disease. Recent studies suggest that dysbiosis may be pathogenic in disorders of hypopigmentation, such as progressive macular hypomelanosis and lichen striatus.
Focusing attention on X-linked ichthyosis
This commentary focuses on some new literature about XLI that demands our attention.
January 17, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 17, 2024 ... Risk of skin cancers in patients with actinic keratoses DermWorld Insights and Inquiries : A cold abscess remains a cold case — Multiple neonatal staphylococcal cold abscesses
March 26, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 26, 2025 ... What’s the best way to dissolve fillers with hyaluronidase? DermWorld Insights and Inquiries : Propranolol for infantile hemangiomas — Start to finish 2025 Allergen of the Year
Finding the right treatments for genetic hair loss
Early diagnosis and treatment can prevent hereditary hair loss from worsening and regrow hair, says board-certified dermatologist. VANCOUVER, BC. (July 21, 2022) — Hereditary hair loss, also known as androgenetic alopecia or pattern hair loss, is the most common form of hair loss in both men and women, affecting millions
How to examine your skin for skin cancer
Board-certified dermatologist shares 5 skin cancer exam tips ROSEMONT, Ill. (May 31, 2023) — Last year, 69-year-old Isabel Lievano's board-certified dermatologist diagnosed the persistent black spot under her nail as melanoma, the deadliest form of skin cancer. Though she lost her nail, she was thrilled that her dermatologist was able
What is being recommended to patients on social media?
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, October 1, 2023 Social media is abundant with skin care advice. A recent ... JAAD cross-sectional analysis of acne treatments on YouTube found that up to 91% of teens report using social media to access health information. However, who is
Atrophic tinea versicolor: More than a mirage?
On occasion I would examine a patient with tinea versicolor and wonder if the finely scaly patches were atrophic. Somehow, I figured (possibly mistakenly) that it was more of an optical illusion than genuine atrophy.
Drug pricing and prior authorization
Access the Academy's resources and tools on drug pricing and prior authorization. Use an automated letter generator to ease the burden of seeking prior authorizations, or learn about the pitfalls of step therapy. Find drug prices in real time or access educational materials that you can share with your patients.
Protecting patients one state at a time
The AADA advocates for a physician-led, team-based approach to care that ensures both safety and best outcomes for each patient and against state legislation that weakens the quality and safety of specialty care.
Documentation and reporting requirements for adjacent tissue transfer or rearrangement
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Senior Manager, Coding and Reimbursement, June 1, 2025 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . Adjacent tissue transfer (ATT) or rearrangement procedures
What dermatology practices need to know about laws protecting pregnant and lactating employees
Legally Speaking ... Robert M. Portman, JD, MPP, is a health care attorney with Powers Pyles Sutter & Verville, in Washington, D.C. ... By Ben Tesdahl, JD, LLM, Jason Qu, JD, and Rob Portman, JD, MPP, September 1, 2024 Every month , DermWorld ... covers legal issues in "Legally Speaking."
Striving to alleviate the physical and emotional scars of central centrifugal cicatricial alopecia
Read the November 4, 2020 DermWorld Insights and Inquiries on central centrifugal cicatricial alopecia.
Dupilumab: The first year
When introduced as dermatologist to a new acquaintance, I’m sure you have heard: “Dermatology is a great field – you don’t cure anybody, so they keep coming back!” Trust me. It’s no joy to see patients with recalcitrant, severe, life-altering, debilitating diseases such as atopic dermatitis, psoriasis, recalcitrant mycosis fungoides, et
Homing in on hornerin: Breaking down the barrier to understand its crucial role in atopic dermatitis
Maintaining the skin barrier is crucial in managing patients with atopic dermatitis. The pathomechanism(s) of barrier impairment is complex and integrally associated with immune dysregulation. Research on newly discovered proteins in the stratum corneum, such as hornerin, may lead to novel therapeutic interventions.
Rounds on pityriasis rotunda
Pityriasis rotunda is a striking dermatosis with many reported associations, most notably as a paraneoplastic process in some cases.
What's hot?
What's hot ... May 29, 2018 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Edward W. Cowen, MD, MHSc ... You may be surprised to learn that a ... new organ’ in the skin was recently identified.
Employee voices
Go to AAD Home ... Go to AAD Home ... Menu ... Dermatologists offer first-person perspectives on life as an employed physician ... Dermatologists offer first-person perspectives on life as an employed physician ... By Emily Margosian, assistant editor For the average dermatologist 20 years ago, starting a career also
Disaster relief preparedness
Answers in Practice ... By Swapna Pachauri, MPH, manager, Health Technology & Informatics, June 1, 2021 Each month DermWorld ... tackles issues "in practice" for dermatologists. This month Swapna Pachauri, MPH, the Academy’s Health Technology & Informatics manager, offers a summary of disaster relief preparedness. Disasters and emergencies can happen
October 3
Learn more about October 3 at aad.org
New American Academy of Dermatology survey: increasing number of Americans at risk of skin cancer despite knowing how to protect themselves
Board-certified dermatologist urges public to practice safe sun ROSEMONT, Ill. (April 30, 2024) — Abby Weiner knew the dangers of unprotected sun exposure long before she was diagnosed with skin cancer. As someone with fair skin and freckles, the 43-year-old mother of three says she has always been diligent about
What's hot?
What's hot ... February 28, 2018 In this monthly column, members of ... Dermatology World 's Editorial Advisory Workgroup identify exciting news from across the specialty. ... Rosalie Elenitsas, MD ... Malignant melanoma is one of the most serious diagnoses that dermatologists face on a regular basis. While many cases
'Stepping up' to off-label dosing of biologics
Read the April 6, 2022 DermWorld Insights and Inquiries on off-label dosing of biologics.
January 26, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 26, 2022 ... Allergens in hand sanitizers DermWorld Insights and Inquiries : Eccrine syringofibroadenoma — Sweating over the details Derm Coding Consult : Applying 2021 E/M coding concepts in everyday
Managing dermatologic care in a COVID-19 hot zone
Dermatology World Weekly talks to Ronda Farah, MD, assistant professor in the department of dermatology at the University of Minnesota Medical School, about her efforts to collect emergency supplies for front line workers.
Americans lack basic health insurance literacy
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, March 1, 2023 A recent Forbes Advisor survey of 2,000 Americans who have health insurance found that while most policyholders report they’re happy with their coverage, many don’t understand it.According to the survey, over three-quarters of participants were unable to
Trichophyton indotineae infections and other severe or antifungal-resistant dermatophytoses
Dermatophytosis (ringworm, tinea, jock itch, athlete’s foot) is a very common and typically minor infection of the skin caused by dermatophyte fungi. In the past decade, severe or antifungal-resistant dermatophytoses have become a global public health concern, including in the United States.
The AADA advocates for truth in advertising
The AADA advocates for increased transparency in healthcare, supporting policies for disclosure of qualifications, visible identification, and public education campaigns. They also endorse truth in healthcare marketing legislation to protect patients from misleading advertising.
AADA fights unsafe scope expansions and misleading advertising
In 2025, the Academy took on several scope expansion and truth-in-advertising bills in partnership with state dermatology and medical societies. The AADA advocates for a physician-led, team-based approach to care that ensures the safety and best outcomes for each patient. We fight against state legislation that weakens the quality and
Will PD-1 inhibitors be msed for Mastocytosis?
The authors evaluated 16 specimens from 12 patients with mastocytosis, using immunohistochemical stains for PD-L1, CD-117, and mast cell tryptase on all specimens.
Documenting the specificity of ICD-10-CM
Access guidance on documenting specificity in ICD-10-CM. To ensure timely reimbursement, dermatologists should document to the required level of specificity in the medical record.
Can dermatologists modulate the microbiome?
New research reveals how the microbiome is reshaping care for inflammatory skin conditions and skin cancer. ... Feature ... By Emily Margosian, Senior Editor , October 1, 2026 Over the last decade, a growing body of research has begun to transform how dermatologists understand and treat inflammatory skin diseases and
Measuring a lesion and choosing the appropriate excision code
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Lead Coding and Reimbursement Strategist, June 1, 2024 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . Benign and malignant lesions present significant
An encapsulation of palisaded encapsulated neuromas
Case reports and retrospective studies have demonstrated dupilumab’s efficacy in treating bullous pemphigoid. Preliminary data from a prospective trial confirms dupilumab’s therapeutic value. Perhaps approval of dupilumab for bullous pemphigoid is on the horizon.
What are the updated guidelines of care for the management of primary cutaneous melanoma?
Acta Eruditorum ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, December 3, 2018 In this month’s Acta Eruditorum column, Physician Editor Kathryn Schwarzenberger, MD, talks with Susan M. Swetter, MD, and
Cosmetic complications
Dermatologists offer insight and instruction for approaching procedural afflictions. ... Feature ... By Laura Vernaci, Contributing Writer, September 1, 2025 It goes without saying that dermatologists do everything in their power to keep their patients safe and avoid complications or adverse events. However, stay in the business long enough and
This month's news from across the specialty
What's hot ... November 1, 2019 In this monthly column, members of ... Dermatology World 's Editorial Advisory Workgroup identify exciting news from across the specialty. ... EDWARD W. COWEN, MD, MHSc Adalimumab was approved in 2015 for the treatment of moderate and severe hidradenitis suppurativa (HS). It is
Questions and answers: Evaluation and management (E/M) guidelines
Working with the AMA, the AAD’s coding experts are here to provide you with insightful solutions to your most common inquiries. In this informative question-and-answer article previously published in AMA CPT Assistant FAQ of August 2023, our coding team delves into the intricacies of coding for the repair of contiguous
American Academy of Dermatology survey shows outdoor workers more at risk for skin cancer than average Americans
Board-certified dermatologist encourages those who work outside to utilize proper sun protection ROSEMONT, Ill. (May 7, 2024) — A recent American Academy of Dermatology survey of more than 1,000 U.S. adults revealed that outdoor workers — like those who work in construction, landscaping, emergency medical services, and postal delivery —
Think that DIY acne trick is helping? Here’s what dermatologists want you to know
Board-certified dermatologist provides tips for clearer skin ahead of Acne Awareness Month ROSEMONT, Ill. (May 27, 2025) — Acne is one of the most common skin conditions, affecting nearly 85% of people at some point in their lives. With people increasingly turning to social media for skin care advice, at-home
Once I receive a CLIA certificate, how do I comply?
Learn how to comply with CLIA once you've received a certificate. This page describes for main steps for complying, which include developing a lab procedures manual, implementing a quality assessment program, potentially enrolling in a proficiency testing program for some practices, and preparing for a CLIA inspection, if applicable.
What is a quality measure?
Learn about the different types of quality measures and how dermatologists can use them to improve care and maximize reimbursement. Quality measures are valuable for reasons apart from reimbursement, and quality improvement programs can contribute to significant improvements in care.
Skin cancer/ melanoma
Cutting giant congenital nevi down to size molecularly Calcipotriene and 5-fluorouracil: Dermatology’s new dynamic duo? Rejecting preconceived notions of squamous cell carcinomas in patients experiencing transplant rejections Biting my nails worrying about atypical presentations of nail unit melanomas 41’s gracious contribution to skin cancer awareness Dermatopathology reports about basal cell
How should I prepare for a CLIA inspection?
Learn how to prepare for a CLIA inspection and avoid common deficiencies. Ensure your lab has proper procedures and documentation to pass the assessment. Get tips for common CLIA deficiencies found in dermatology practices.
Not otherwise specified or not elsewhere classifiable
Learn about the differences in Not Other Specified (NOS) and Not Elsewhere Classifiable (NEC) codes. Understand why you should use one code versus the other in a given scenario.
Mailing lists
The Academy's membership list is more current and accurate than any other dermatology list available in the market.
Cover your assets
Go to AAD Home ... Go to AAD Home ... Menu ... Experts offer tips on getting the most out of malpractice insurance ... Experts offer tips on getting the most out of malpractice insurance ... By Ruth Carol, contributing writer You may not be paying for your medical malpractice
Tackling itch
Understanding and treating chronic itch ... Feature ... By Allison Evans, Assistant Managing Editor, April 1, 2022 Itch, or pruritus, is a common symptom (and condition) that is considered one of the 50 most prevalent conditions worldwide — an estimated 15% of the population suffers from chronic pruritus. Speak to
Tarrying for tapinarof
Read the January 12, 2022 DermWorld Insights and Inquiries on tapinarof.
Nonepidemic Kaposi sarcoma: The fifth dimension
By Warren R. Heymann, MD Oct. 16, 2019 Vol. 1, No. 32 ... For more than a century, since first described in 1872 by Moritz Kaposi* as "idiopathic multiple pigmented sarcoma," dermatologists focused on classical Kaposi sarcoma (KS) — violaceous patches, plaques, and tumors on the lower extremities of
Coming to grips with lymphocytic thrombophilic arteritis
Read the May 18, 2022 DermWorld Insights and Inquiries on lymphocytic thrombophilic arteritis.
Fighting for truth in advertising in Indiana
Ask the Expert ... By Victoria Houghton, Managing Editor, August 1, 2022 DermWorld ... spoke to Carrie Davis, MD, FAAD, former chair of the Government Affairs and Advocacy Committee at the Indiana Academy of Dermatology, about efforts with the American Academy of Dermatology Association (AADA) to advocate for truth in
Wolf’s isotopic response: Where and when
Although the nature of Wolf’s isotopic response may be debated among dermatologists, clinicians must recognize that new rashes and tumors may appear in sites of previously healed sites from other disorders, most frequently herpes zoster.
The aryl hydrocarbon receptor: Tapinarof is taking off
The aryl hydrocarbon receptor plays a key role in inflammation. Understanding its pathophysiology has led to new therapeutic agents such as tapinarof, which is approved for psoriasis and atopic dermatitis, and used off-label in lupus, vitiligo, ichthyotic diseases, and perioral dermatitis.
Lipodystrophia semicircularis: A lipoatrophy not to get depressed about
Read the Nov. 2, 2022 DermWorld Insights and Inquiries on lipodystrophia semicircularis.
Transplantation dermatology: Race matters
December 3rd, 2017 will mark the 50th anniversary of the first human-to-human heart transplant performed by the late South African cardiothoracic surgeon, Christaan Barnard.
The journey of focal dermal hypoplasia: From description to inspired therapy
The dermatologic community lost a giant in 2014 with the passing of Robert W. Goltz, MD at the age of 90. Dr. Goltz was not only responsible for describing focal dermal hypoplasia (FDH), but also multicentric reticulohistiocytosis, generalized elastolysis, and the nevoid basal cell carcinoma syndrome (with his good friend
Striae due to bartonella is a stretch
I met a woman in her early 20’s who is being treated for chronic Lyme disease and Bartonella infections with multiple courses of antibiotics. During my examination, I noted several old white atrophic striae on her hip and leg. Her mother, who was accompanying her, stated matter-of-factly, “Those are due
Reporting Mohs micrographic surgery with a simple repair
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Coding & Reimbursement, February 1, 2022 Academy coding staff address important coding topics each month in DermWorld Coding Consult. ... Read more Derm Coding Consult articles . The Integumentary System, Repair (Closure) guidelines were recently
Giving thanks
From the President ... Dr. Desai served as Academy president from March 2024 to March 2025. ... By Seemal R. Desai, MD, FAAD, November 1, 2024 Dear members, ... I hope everyone is enjoying their autumn so far! ... Last month kept me busy doing one of my favorite things:
This month's news from across the specialty
What's hot ... November 1, 2021 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Craig Burkhart, MD, MPH, MSBS, FAAD Health care support workers (phlebotomists, medical assistants, licensed practical nurses, nursing aides, and medical secretaries) are essential
Oncolytic virotherapy and the dermatologist
My late British cousin Tim, a brilliant, kind, benevolent husband, father, gastroenterologist, and MBA, lost his battle with glioblastoma in 2016 at age 55.* I was hoping that he might be able to get into a trial using an oncolytic virus (OV), but that was not possible.
October 31
Learn more about October 31 at aad.org
Additional Reasons Payers Request Records
Learn about additional reasons why payers request records.
A dermatologist’s guide to skincare from growing up to glowing up
Board-certified dermatologist (and mom) shares holiday shopping tips for teens and tweens. ROSEMONT, Ill. (Oct. 28, 2025) — As online skincare trends continue to capture the attention of tweens and teens (and major retailers roll out early holiday promotions), an AAD board-certified dermatologist offers guidance to help families cut through
Reporting excimer laser therapy: When to use 96999 vs 9692x
As a result of a code descriptor change for CPT codes 96920-96922 effective Jan. 1, 2024, these codes are now to be used only for excimer laser treatment of psoriasis.
Tips for avoiding fraud and abuse liability – Part I
Legally Speaking ... By Christina A. Hughes, JD, MPH, Megan La Suer, JD, MHA, and Robert M. Portman, JD, MPP, January 1, 2022 Every month, DermWorld ... covers legal issues in "Legally Speaking." This month’s authors are health care attorneys with Powers Pyles Sutter & Verville in Washington, D.C. Portman
Fixing the concept of the neutrophilic fixed drug eruption
Read the Oct. 12, 2022 DermWorld Insights and Inquiries on fixing the concept of the neutrophilic fixed drug eruption.
June 28, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE/ June 28, 2023 ... A beneficial botanical extract for actinic keratosis? DermWorld Insights and Inquiries : Dermatologic ergonomics — Straighten up and fly right FDA approves alopecia areata treatment in adults and
Support system
Go to AAD Home ... Go to AAD Home ... Menu ... Dermatologists step in to treat cutaneous side effects of cancer treatments so patients can complete their therapy ... Dermatologists step in to treat cutaneous side effects of cancer treatments so patients can complete their therapy ... By Ruth
Sirolumus’s merit for the Kasabach-Merritt phenomenon
We wish to report the following case of an extensive hemangioma of the skin associated with diffuse purpuric manifestations. The course and management of the condition, we believe, are of unusual interest.
This month’s news from across the specialty
What’s hot ... October 1, 2025 In this monthly column, members of the DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty. Rosalie Elenitsas, MD, FAAD Pathologists and dermatopathologists frequently encounter poorly differentiated tumors that fail to reveal a defined lineage. In cutaneous specimens, these are
Hand-wringing over the histology of mechanic’s hands and other cutaneous manifestations of dermatomyositis
Of all the cutaneous manifestations of dermatomyositis (DM) – the heliotrope rash, Gottron’s papules, Gottron’s sign, shawl sign, holster sign, flagellate erythema, photosensitivity, poikiloderma, periungual erythema, periungual telangiectasis, Samitz sign, pruritic erythema of the scalp, and panniculitis – none has perplexed me more than mechanic’s hands (MH).
The H syndrome – Understanding Y
Read the April 15, 2020 DermWorld Insight and Inquiries on H syndrome.
March 1, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 1, 2023 ... Isotretinoin: Risk of IBS, ulcerative colitis, and Crohn’s disease? DermWorld Insights and Inquiries : Seeing red with dupilumab IL-17 inhibitors in psoriasis patients in the real world
April 5, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 5, 2023 ... What’s the effect of probiotics on skin photoaging? DermWorld Insights and Inquiries : An appealing step closer to targeted topical therapies Does nicotinamide prevent keratinocyte cancers in
Learning about proton pump inhibitor-induced dermatologic adverse reactions is ulcerogenic
How many of your patients are on protein pump inhibitors (PPI) such as Nexium [esomeprazole], Prevacid [lansoprazole], or Prilosec [omeprazole] for GERD? Let me rephrase the question. How many of your patients are NOT on PPI’s?
Scratching from A Hard Day’s Night? Meet the beetles!
One of my least favorite encounters in dermatology is telling patients that it looks like they have insect bites.
Review of systems (ROS)
Review of Systems (ROS) is an inventory of body systems that you get from asking patients about their symptoms. If you don’t code the ROS correctly, you can end up down-coding, which isn’t good for your patient’s outcome or your bottom line.
Americans with Disabilities Act issues in dermatology
Legally Speaking ... Robert M. Portman, JD, MPP, is a health care attorney with Powers Pyles Sutter & Verville, in Washington, D.C. ... By Ben Tesdahl, JD, Megan La Suer, JD, MHA, and Robert M. Portman, JD, MPP, January 1, 2021 Every month, DermWorld ... covers legal issues in "Legally
Go your own way
Dermatologists share experiences and considerations practicing in a variety of practice models. ... Feature ... By Allison Evans, Assistant Managing Editor, September 1, 2025 Whether you’re embarking on your career path, or you’re simply ready for a reset, there are a multitude of practice models to investigate. Each path offers
Avoid the opioid
Experts offer advice on effective pain management in dermatology. ... Feature ... By Heidi Splete, Contributing Writer, May 1, 2026 Many dermatoses and dermatologic procedures are painful, but consensus on pain management in dermatology is limited, and complicated not only by the individual and varied experience of pain, but also
This month's news from across the specialty
What's hot ... December 1, 2020 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Harry Dao Jr., MD Choice and transparency dominate our landscape. It is hard to believe that it was only 2013 when the FDA
Coding and documentation clarity
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, April 2, 2018 You biopsy a suspected drug eruption and document the following: "Punch biopsy done. Return in 1
Humbled again: Alopecic and aseptic nodules of the scalp
Read the November 3, 2021 DermWorld Insights and Inquiries on alopecic and aseptic nodules of the scalp.
Paradoxical biological reactions and Grandma Dora’s waterbed
Read the January 22, 2020 DWII on paradoxical biological reactions.
It's time for a CLIA refresher!
In Practice ... Faiza Wasif, MPH, is the AAD's practice management manager. Her column offers tips on an area she commonly receives questions about from members. ... By Faiza Wasif, MPH, August 1, 2019 What comes to mind when you hear CLIA? Probably that it’s just another burdensome federal regulation
Using trusts to shield assets from potential liability
Money Matters ... David B. Snyder, JD, CLU ... ® ... , is an attorney, author, and financial advisor at the wealth management firm OJM Group. He covers financial issues for dermatologists in this quarterly ... Dermatology World column. ... By David B. Snyder, JD, CLU, September 3, 2018 Given
March 24, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 24, 2021 ... Derm Coding Consult : Applying 2021 E/M coding concepts in everyday practice — Part 1 DermWorld Insights and Inquiries : Lipschütz ulcers — Not only for women
January 30
Learn more about January 30 at aad.org
Protecting privacy
Protecting patient privacy is at the heart of HIPAA. Find out what you have to do to comply.
What to consider before selling your practice to a private-equity-backed group?
Considering selling your dermatology practice to a private equity-backed group? Learn about the pros and cons, including potential financial risks, and what corporate dermatology groups look for in a practice. Discover how to get the best offer for your practice and find resources for preparing a practice sale contract, valuing
Cosmetic treatments
By communicating these key messages on cosmetic treatments, you can help position the specialty while increasing your credibility and raising the profile of your practice. Review key messages tailored to the different kinds of cosmetic treatments, including fillers, botulinum treatment, liposuction, and more.
A second set of eyes
As states consider new chaperone rules for skin checks, what do they mean for your patients and practice? ... Feature ... By Emily Margosian, Senior Editor, July 1, 2025 In dermatology, the physical exam is a core part of nearly every patient encounter, requiring mutual trust between patient and physician.
Checking in on immune checkpoint inhibitors
Immune checkpoint inhibitors offer hope for non-melanoma skin cancer patients ... Feature ... By Heidi Splete, Contributing Writer, July 1, 2022 Patients with advanced non-melanoma skin cancer see new hope on the horizon, thanks to recent developments in the number and effectiveness of new drugs to improve survival. ... "Patients
Entering a golden age of toxins
Go to AAD Home ... Go to AAD Home ... Menu ... As more drugs and treatment indications receive FDA clearance, how do the new arrivals compare to industry heavyweights? ... As more drugs and treatment indications receive FDA clearance, how do the new arrivals compare to industry heavyweights? ...
Dupilumab treatment of bullous pemphigoid: Hoping for approval on the double
Case reports and retrospective studies have demonstrated dupilumab’s efficacy in treating bullous pemphigoid. Preliminary data from a prospective trial confirms dupilumab’s therapeutic value. Perhaps approval of dupilumab for bullous pemphigoid is on the horizon.